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Introduction:  Obesity is associated with insulin resistance often accompanied by 
hyperinsulinemia and hyperglycemia, placing obese individuals at risk for type 2 diabetes and 
other chronic diseases.  Acute exercise is associated with a decrease in postprandial insulin and 
glucose, but it is unknown how exercise of varying duration affects these variables.  Purpose:  
The purpose of this study was to compare changes in postprandial insulin and glucose following 
10-minutes (10-EX) and 30-minutes (30-EX) of aerobic exercise to a resting (REST) condition.  
Methods:  9 healthy, sedentary obese men and women (BMI: 33.6±3.2 kg/m2; Age: 45.3±5.7 
years) each performed 10-EX, 30-EX and REST in a randomized fashion.  Blood was collected 
in the fasting state, and at 30-minute intervals following breakfast for 120-minutes.  All exercise 
sessions were performed at 70-75% maximal heart rate.  Results:  Data was collected at all time 
points for five subjects, which were included in area under the curve (AUC) analyses.  There was 
no significant difference in plasma insulin AUC between REST (12,270±6,148), 10-EX 
(10,633±5,162), and 30-EX (11,479±4,810) (p=0.354).  There was no significant difference in 
plasma glucose AUC between REST (23,184±6,023), 10-EX (21,735±2,680), and 30-EX 
(22,899±3,328) (p=0.554).  However, the patterns of change were not consistent across 
experimental conditions.  A significant main effect for condition (p=0.018) was detected at 60-
MIN for insulin, with lower insulin observed in 30-EX (32.3±12.3) compared to 10-EX 
(66.8±30.3) or REST (94.9±48.0).  Insulin rebounded following exercise and was significantly 
higher at 120-MIN in 30-EX (74.3±45.2) compared to REST (55.4±45.7) (p=0.042).  Plasma 
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glucose followed a similar pattern, and a significant main effect was observed at 90-MIN 
(p=0.037) at was elevated in 30-EX (147.6±29.0) compared to 10-EX (122.2±21.5) or REST 
(121.4±38.0).  Conclusion:  There was no significant difference in plasma insulin or glucose 
AUC between 10-EX, 30-EX and REST, but pattern of change was not consistent across 
conditions. Additional research should explore if differences in pattern of change following 10- 
or 30-minutes of exercise affect health outcomes in obese adults. 
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1.0  INTRODUCTION 
1.1 OBESITY AND INSULIN RESISTANCE 
The prevalence of obesity in the United States has reached epidemic proportions, with an 
estimated 33.8% of adults classified as obese as of 2008.1  Obesity is associated with increased 
risk for several chronic diseases including type 2 diabetes mellitus, cardiovascular disease, 
certain forms of cancer, sleep apnea and osteoarthritis.2    While the etiology of obesity is 
complex, the underlying cause is excess of energy consumed beyond what is expended.  This 
excess energy is stored as fat in adiopocytes, resulting in adipocyte hypertrophy and hyperplasia 
and causing dysfunction of adiopocytes.  This adipocyte dysfunction appears to be the 
mechanism responsible for initiating a multitude of  obesity-associated health consequences, 
including insulin resistance.3 
Insulin resistance is defined as a state in which a given amount of insulin produces a less 
than normal biological response, and is considered a major risk factor associated with obesity.4 
Insulin resistance and accompanying hyperinsulinemia increase risk for several chronic diseases, 
with a particularly strong link to diabetes and cardiovascular disease.  As a patient becomes 
insulin resistant, β-cells in the pancreas compensate by producing extra insulin to maintain blood 
glucose.  Over time, β-cells may begin to produce less insulin or ultimately cease insulin 
production.  This β-cell failure results in hyperglycemia and eventually leads to type 2 diabetes.   
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Obesity appears to contribute to insulin resistance by two primary mechanisms:  
increased circulation of free fatty acids (FFA)5 and inflammation associated with adipocyte 
dysfunction.6-7  The excess adipose tissue that leads to obesity results in elevated rates of 
lipolysis, causing increased concentrations of FFAs in the bloodstream.  Increased plasma FFA 
attenuates insulin-stimulated glucose uptake8 and increases gluconeogenesis by the liver, 
resulting in a state of increased glucose production and decreased glucose uptake.2 
Obesity is also associated with increased systemic inflammation, which also contributes 
to insulin resistance. Chronic excessive energy intake leads to adipoctye enlargement, causing 
the endoplasmic reticulum to trigger the unfolded protein response (UPR). This initiates an 
inflammatory response and macrophage activation.6   The inflammatory mediators secreted as 
part of the inflammatory response are thought to contribute to insulin resistance.9 
1.2 HEALTH CONSEQUENCES OF HYPERINSULINEMIA 
Insulin resistance is a health concern as it may progress to β-cell insufficiency or failure, 
resulting in the development of type 2 diabetes.  However, hyperinsulinemia that exists early in 
the development of insulin resistance is associated with health complications and development of 
chronic disease that is not limited to type 2 diabetes.  There is evidence specifically linking 
insulin resistance and hyperinsulinemia with cardiovascular disease, hypertension, 
hyperlipidemia, non-alcohol fatty liver disease, and polycystic ovarian syndrome. 
Fasting insulin has been reported to predict cardiovascular disease risk.  In a cohort of 
men and women aged 25-64 from the San Antonio Heart Study, elevated fasting insulin was 
associated with increased risk for cardiovascular disease.10 Additionally, in a group of non-
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diabetic older men, risk of cardiovascular events was greater among individuals in the highest 
quartile of fasting plasma insulin when compared to those in lower quartiles.11 Accelerated 
progression of atherosclerosis is associated with high fasting insulin, and hyperinsulinemia may 
also predict more complex atherosclerotic lesions.12 The increased rate and complexity in 
atherosclerotic developement in patients with high fasting insulin provides a potential 
mechanistic link between hyperinsulinemia and increased risk for cardiovascular disease.   
High fasting insulin is associated with several cardiovascular disease risk factors, 
particularly dyslipidemia and hypertension.  Hyperinsulinemia may contribute to high 
triglyceride levels and low concentrations of HDL cholesterol.13 Elevated insulin levels are also 
common in hypertensive patients.  A prospective study of middle-aged men reported that fasting 
insulin and insulin response to an oral glucose tolerance test (OGTT) were significant risk factors 
for the development of hypertension.14 Thus, it is possible that insulin plays a role in the 
pathogenesis of hypertension and dyslipidemia, which may also explain the association between 
increased risk of cardiovascular disease and insulin resistance.   
Hyperinsulinemia also contributes to the development of other conditions, particularly 
non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS).  For 
example, in a 5-year prospective study, patients with increased fasting insulin were at higher risk 
for NAFLD compared to patients with lower fasting insulin levels.15 Additionally, insulin 
resistance and accompanying hyperinsulinemia is also considered an integral component in the 
pathogenesis of PCOS.16 
While obesity plays a critical role in the development of insulin resistance, resulting 
hyperinsulinemia may accelerate weight gain or inhibit weight loss.  The role of insulin is to 
facilitate glucose uptake for use and storage in the tissues, and insulin levels are reported to 
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predict weight gain over time.17-18  Insulin resistance is associated with obesity, and 
hyperinsulinemia may perpetuate weight gain, creating a cycle of increasing levels of obesity and 
insulin resistance.  
1.3 EFFECT OF EXERCISE ON INSULIN AND GLUCOSE 
It is important to explore therapeutic methods for decreasing insulin resistance and 
hyperinsulinemia to delay the onset of diabetes and cardiovascular disease, and prevent the 
additional health consequences associated with insulin resistance.  Exercise is one purported 
method for decreasing insulin resistance.  Both acute and chronic exercise is associated with 
improvements in insulin sensitivity, and decreased circulating insulin and glucose. 
A single bout of moderate-intensity aerobic exercise has also been shown to improve 
insulin sensitivity among adults with varying degrees of insulin resistance.  Improved insulin 
resistance has been reported in healthy men and women when measured 12-hours following a 
one- to two-hour bout of aerobic activity performed at 60% VO2peak.19  Improved insulin action 
has also been observed in both diabetic and nondiabetic obese adults. Cusi et al. reported that in 
a group of obese nondiabetics, one hour of aerobic exercise at 65% VO2max increased insulin 
stimulated glucose uptake during a hyperinsulinemic euglycemic clamp.20 Similarly, Burstein et 
al. observed an improved insulin response during a hyperinsulinemic euglycemic clamp 
following 45 minutes of exercise at 50% VO2max in both diabetic and nondiabetic obese adults.21 
Acute exercise is also associated with decreased postprandial plasma insulin and glucose in 
diabetics.  For example, Larsen et al. had older men with diabetes exercise for 45 minutes at 50% 
VO2max after consuming breakfast, and observed significant decreases in glucose and insulin 
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throughout the post-exercise period.22 These studies collectively indicate that a single session of 
continuous, aerobic exercise acutely improves insulin resistance and decreases plasma insulin 
and glucose concentrations.   
The effect of exercise on insulin and glucose is transient, lasting for a period of 2 to 72 
hours following exercise.23-25 King et al. observed this short-tem improvement in insulin 
sensitivity in a group of trained subjects.  These subjects completed five consecutive days of 
aerobic training, followed by seven days of inactivity.  Insulin sensitivity was improved one and 
three days following exercise, but returned to baseline values by the fifth day of inactivity.23 
Similar results were reported by the HERITAGE study. Following a 6-week aerobic training 
program, fasting insulin levels were significantly lower 24-hours following the final exercise 
session but had returned to baseline by 72 hours post-exercise.25 
 Current health recommendations suggest that adults perform a minimum of 30-
minutes of moderate intensity aerobic exercise on most days of the week.  These guidelines also 
state that aerobic activity does not need to be performed in one continuous session, but may be 
accumulated in 10-minute bouts. 26-28 Performing multiple sessions in minimum 10-minute bouts 
appears to have a similar effect on weight29-31 and cardiovascular fitness29-36 as performing one 
continuous exercise bout.  However, the effectiveness of short bouts for improving other health 
outcomes such as insulin and glucose is currently unknown.     
Although the effect of short bouts for decreasing insulin and glucose has not yet been 
determined, guidelines for exercise training in populations characterized by hyperinsulinemia 
and hyperglycemia (e.g., obese and diabetic individuals) suggest accumulating short bouts to 
meet physical activity requirements.24, 28  However, the chronic effect of accumulating short 
bouts of exercise on insulin and glucose is not yet understood, and the limited research on this 
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topic has presented equivocal results.  For example, Donnelly et al. reported a decrease in both 
fasting insulin and insulin response to an OGTT following 18 months of exercise training 
consisting of two, 15-minute sessions performed 5 days per week.32 Conversely, Eriksen et al. 
recently reported that fasting plasma glucose and glucose response to an oral glucose tolerance 
test (OGTT) were significantly lower following intermittent exercise training compared to 
continuous training.  However, there was no change in insulin in either group.37 Based on these 
two studies, the efficacy of intermittent exercise for decreasing insulin and glucose in obese 
adults is unclear, indicating a need for additional research.  
While it is possible that accumulating exercise in multiple bouts decreases insulin and 
glucose as effectively as continuous exercise training, few studies have explored whether there is 
a difference in these sessions following acute exercise.  Most studies investigating the acute 
effect of intermittent versus continuous exercise have done so in a healthy, normal weight 
population and performed measurements of insulin resistance 12 or more hours following the 
final exercise bout.38-39 Currently only one study has examined the acute effect of short bouts of 
exercise in a population that included obese subjects.40 However, this study included subjects 
with a BMI range from healthy to obese (23.9kg/m2 to 34.5 kg/m2), making it difficult to 
generalize these results specifically to an obese population.   Therefore, the insulin and glucose 
response immediately following short bouts of exercise compared to continuous exercise is 
currently unknown in an obese population. It is possible that multiple short bouts of activity 
result in transient improvements in hyperinsulinemia and hyperglycemia that are additive and 
more effective for decreasing insulin and glucose compared to one single bout of equal duration.  
However, no study has yet explored this question. 
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1.4 GAPS IN THE LITERATURE 
Exercise training is an effective means for decreasing insulin and glucose.  However, the 
literature does not currently indicate if accumulating short bouts of exercise is as effective as one 
continuous bout for decreasing plasma insulin and glucose.  Few studies have examined this 
topic, and methodological differences make interpretation of results difficult.  In order to most 
effectively explore the effect of accumulating short bouts of exercise, it would be helpful to 
know how a single 10-minute bout of aerobic activity affects measures of insulin and glucose.  It 
is possible that a single ten-minute bout does not improve insulin or glucose beyond what is 
observed in a resting state, and that performing short bouts throughout the day would have little 
impact on insulin and glucose concentrations.  However, 10-minutes of exercise may 
significantly improve insulin and glucose, suggesting that multiple bouts may be preferable to 
one 30-minute session.  Therefore, the aim of this study was to determine the effect of a 10-
minute and 30-minute exercise session compared to a resting condition on changes in insulin and 
glucose. 
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1.5 SPECIFIC AIMS 
The specific aims of this study were: 
1. To compare the effect of three conditions [30-minutes of aerobic exercise (30-EX), 10-
minutes of aerobic exercise (10-EX) or a resting condition (REST)] on postprandial plasma 
insulin over a 2-hour observation period. 
2. To compare the effect of three conditions [30-EX, 10-EX, REST] on postprandial plasma 
glucose over a 2-hour observation period. 
1.6 HYPOTHESES 
1. It was hypothesized that the 10-EX condition would result in a greater decrease in postprandial 
insulin compared to the REST condition.  
2. It was hypothesized that the 30-EX condition would result in a greater decrease in postprandial 
insulin compared to the 10-EX condition. 
3. It was hypothesized that the 10-EX condition would result in a greater decrease in postprandial 
glucose compared to the REST condition.  
4. It was hypothesized that the 30-EX condition would result in a greater decrease in postprandial 
insulin compared to the 10-EX condition. 
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1.7 CLINICAL RATIONALE 
The clinical rationale for this study was that the effect of short bouts of exercise, defined as ten 
minutes, is currently unknown.  This study was the first two address the question of whether 10 
minutes of exercise effectively decreases insulin and glucose compared to a resting condition.  If 
there was no significant change in these measures compared to rest, it is unlikely that 
accumulating 10 minute bouts would result in significant changes in insulin and glucose.  It is 
also possible that 10 minutes of exercise significantly decreases insulin and glucose compared to 
rest, but the magnitude is not as great as what is observed following 30-minutes of exercise.  In 
this instance, it is possible that performing multiple 10-minute sessions would have an equal or 
greater effect as performing a single, longer exercise session for managing insulin and glucose.  
Finally, it is possible that 10 minutes of exercise results in a decrease in insulin and glucose that 
is similar in magnitude as a 30-minute session.  If this effect was observed, it is likely that 
accumulating exercise in 10-minute bouts would result in significantly greater improvements in 
insulin and glucose than performing a single, longer session.  Therefore, this study provides the 
initial data necessary to further explore the effectiveness of accumulating shout bouts of exercise 
to manage insulin and glucose levels in an obese population. 
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2.0  REVIEW OF THE LITERATURE 
2.1 INTRODUCTION 
Obesity is associated with hyperinsulinemia and insulin resistance, predisposing individuals to 
health complication such as cardiovascular disease, NAFLD, PCOS, and continued weight gain.   
Exercise is one treatment for improving insulin resistance.  Both acute and chronic exercise is 
associated with decreased insulin and glucose and improvements insulin resistance. 
Current physical activity recommendations suggest that aerobic activity can be 
accumulated in shout bouts lasting a minimum of 10-minutes.  However, it is not clear if 
accumulating short bouts effectively decreases insulin and glucose.  It is also unknown if short 
bouts of exercise produce changes in insulin that are equal to a longer bout of exercise. Current 
research examining changes the effect of short bouts of exercise on insulin and glucose is limited 
and results are conflicting.32, 37 Therefore it is necessary to further examine the role of short bouts 
of exercise in normalizing insulin levels in obese adults. 
2.2 OBESITY AND INSULIN RESISTANCE 
The prevalence of obesity in the United States has reached epidemic proportions, with an 
estimated 33.8% of adults classified as obese as of 2008.1 Obesity is a public health concern as it 
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associated with increased risk for many chronic diseases including type 2 diabetes mellitus, 
cardiovascular disease, certain forms of cancer, sleep apnea and osteoarthritis.2  Risk of all cause 
mortality also increases with greater levels of overweight and obesity.41 There is a particularly 
strong link between obesity and type 2 diabetes; current estimates are that 82% of diagnosed 
diabetics are overweight and 55% are classified as obese.42      
The connection between obesity and diabetes appears to be obesity-mediated insulin 
resistance.  Insulin resistance is defined as a state in which a given amount of insulin produces a 
reduced biological response.4  Initially, the β-cells of the pancreas respond to insulin resistance 
by producing extra insulin to maintain normal blood glucose levels, resulting in chronic 
hyperinsulemia.  Over time the high output of insulin may cause β-cell failure and deterioration 
in glucose homeostasis; at this point an individual would be diagnosed with type 2 diabetes.  
While prevention of diabetes is a concern, high insulin levels accompanying insulin resistance 
which precedes β-cell failure also negatively impact other health outcomes.5, 13 Therefore, it is 
necessary to explore methods for decreasing elevations in insulin, which accompany insulin 
resistance in non-diabetic populations.   
Obesity is associated with fasting hyperinsulinemia, decreased insulin-stimulated glucose 
uptake, and decreased suppression of hepatic glucose production.43-45 The mechanisms 
contributing to obesity-induced insulin resistance are increased circulation of free fatty acids 
(FFA), ectopic fat distribution, and inflammation associated with adipocyte dysfunction. These 
initial pathologies cause further metabolic disturbances within insulin sensitive tissues, including 
skeletal muscle, adipocytes and hepatocytes.  As these tissues becomes insulin resistant and are 
unable to properly utilize and store glucose for energy, β-cell insulin production continues to 
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increase to maintain glucose homeostasis.  The result is chronic hyperinsulinemia that may 
progress to β-cell failure and hyperglycemia over time. 
2.2.1 Increased FFA 
Obesity is associated with increased plasma FFA,43, 46-47 especially in the presence of elevated 
abdominal adiposity.47   Adipocytes are resistant to the anti-lipolytic effect of insulin in obese 
individuals, resulting in elevated circulating FFA levels.6, 47   Jensen et al. reported a reduced 
suppression in FFA turnover during a eugylcemic and hyperinsulinemic clamp in healthy, obese 
women compared to normal weight women.47  Elevated FFA compromise fuel utilization by 
decreasing insulin-stimulated glucose uptake. Decreased insulin-stimulated carbohydrate uptake 
has been observed following lipid infusion in healthy adults8, 48-50 and type 2 diabetics.51  Belfort 
et al., reported that increasing plasma FFA in a group of lean, healthy adults to levels comparable 
to obese individuals significantly decreased insulin-stimulated glucose uptake. 50  Therefore, 
increased levels of FFA found in obesity are thought to contribute to insulin resistance.   
2.2.2 Ectopic fat distribution 
Chronic elevations in FFA and lipid oversupply due to obesity result in deposition of fatty acids 
in tissues besides adiopocytes, including skeletal muscle and the liver.  This ectopic fat 
deposition is thought to disrupt the normal function of these tissues, resulting in insulin 
resistance.52   Levels of skeletal muscle triglyceride are elevated in obese individuals,45, 53 
contributing to insulin resistance.45, 54-55  Goodpaster et al. reported that increased amounts of 
adipose tissue deposited within skeletal muscle was significantly associated with insulin 
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resistance in obese, glucose tolerant men and women.45  Similarly, Pan et al. demonstrated that in 
a group of 38 non-diabetic male Pima Indians,  higher concentrations of muscle triglyceride were 
significantly associated with insulin resistance while other markers of adiposity (percent body 
fat, BMI, waist-to-thigh ratio) were not.55   
Interestingly, intramyocellular lipid (IMCL) is also elevated in athletes but does not 
contribute to insulin resistance in this population.56  Athletes posses a greater oxidative capacity 
for IMCL, which appears to be why this population is not insulin resistant.56 Additionally, toxid 
lipid intermediates associated with IMCL in obesity, such as diacylglycerols (DAGs) and 
ceramides, are thought to contribute to insulin resistance in this population.57  In a group of 
overweight and obese older adults, Dubé et al. demonstrated that following a 16-week aerobic 
exercise intervention, changes in insulin sensitivity were associated with ceramide content but 
not IMCL.58  Therefore it is thought that the buildup of toxic lipid intermediates is responsible 
for insulin resistance in obese individuals. 
 Fat deposition in the liver also has a particularly strong relationship with insulin 
resistance.  Visceral adipose tissue is associated hepatic lipid accumulation (IHL), and NAFLD 
is prevalent among obese individuals.59  It is thought that lipolytic activity in visceral adipose 
tissue leads to increased delivery of FFA via portal circulation.60   Kelley et al. reported that 
elevated fat content in the liver was significantly associated with severity of insulin resistance 
among obese diabetics.  In this group, individuals with the highest lipid accumulation in the liver 
had significantly lower insulin-stimulated glucose uptake during a euglycemic insulin clamp .59 
IHL may also increase insulin resistance in other insulin sensitive tissues, including the liver, 
adipose tissue and skeletal muscle.  In type 2 diabetics, both hepatic and adipocyte insulin 
resistance are significantly associated with elevated IHL.61  Additionally, Korenlbat et al. 
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reported that IHL amount was directly correlated with impaired insulin action in the liver, 
adipose tissue, and skeletal muscle in a group of nondiabetic, obse adults.62  
2.2.3 Adipocyte dysfunction and inflammation 
In obesity, adiopocytes undergo both hypertrophy and hyperplasia in order to store excess fatty 
acids.  Adipocyte enlargement triggers the unfolded protein response (UPR) in the endoplasmic 
reticulum, causing an inflammatory response and macrophage activation.6  These processes 
result in adipocyte dysfunction and production of reactive oxygen species (ROS), adipokines and 
inflammatory mediators, which are all associated with insulin resistance.3  Obesity is 
accompanied by upregulation of inflammatory pathways such as c-jun N-terminal kinase (JNK) 
and nuclear factor ĸB (NFĸB) signaling, causing overproduction of proinflammatory cytokines.52  
The proinflammatory cytokine tumor necrosis factor-α (TNF-α) appears to play a 
particularly important role in obesity-induced inflammation and insulin resistance.  In vitro 
studies have demonstrated that TNF-α activates the JNK pathway and inhibits insulin receptor 
activation.  This cascade of events results in insulin resistance by reducing the cellular response 
to circulating insulin.63  In addition, TNF-α has been reported to independently predict rates of 
insulin-stimulated glucose uptake in a group of normal glucose tolerant and impaired glucose 
tolerant adults with a range of BMI classifications.64 
Obesity contributes to insulin resistance, hyperinsulinemia and hyperglycemia by several 
potential mechanisms.  Elevated FFA acid levels reduce insulin-stimulated glucose uptake and 
compromise normal fuel utilization in insulin resistant tissues.  High FFA levels also lead to fat 
deposition in skeletal muscle and liver causing these tissues to become insulin resistant.  Finally, 
adipocyte hypertrophy and hyperplasia initiate the upregulation of inflammatory pathways, 
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resulting in secretion of inflammatory mediators and adipokines that compromise insulin 
sensitivity.  Therefore, hyperinsulinemia resulting from insulin resistance often accompanies 
obesity, putting this population at risk for many negative health consequences. 
2.3 HEALTH CONSEQUENCES OF HYPERINSULINEMIA 
While the etiology of insulin resistance is complex, there are several obesity-mediated factors 
that contribute to the development of insulin resistance, hyperinsulinemia and hyperglycemia.  
The initial decrease in insulin sensitivity is compensated by β-cells increasing insulin secretion, 
placing obese individuals in a state of hyperinsulinemia.  While insulin resistance may eventually 
progress to diabetes, there are additional health consequences associated with chronic 
hyperinsulinemia.  These health conditions include coronary artery disease, hypertension, 
dyslipidemia, NAFLD, PCOS, and impaired weight management efforts.  
  Over 20 years ago, Reaven identified hyperinsulinemia and insulin resistance as a central 
risk factor for coronary artery disease, hypertension, and dyslipidemia.5  This clustering of risk 
factors associated with cardiometabolic disease is termed “metabolic syndrome,” and insulin 
resistance is considered the risk factor linking these conditions.  Since Reaven initially identified 
the importance of hyperinsulinemia and insulin resistance, results from additional studies have 
supported the role of hyperinsulinemia in the development of cardiometabolic and other chronic 
disease. 
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2.3.1 Insulin and chronic disease 
Several studies have observed a relationship between hyperinsulinemia and risk for chronic 
disease.  For example, Zavaroni et al. reported that elevated insulin levels following a 75-gram 
OGTT were associated with increased incidence of diabetes, hypertension, and coronary heart 
disease. 65  This prospective study examined 647 healthy factory workers over a period of 12-15 
years.  The incidence of disease was significantly higher for those in the highest quartile for 
insulin level two hours following the glucose load.  Among individuals in the highest insulin 
quartile, risk of diabetes was eight times higher, risk of hypertension was twice as high, and risk 
of coronary heart disease was three times greater compared to individuals in the lower three 
quartiles.  Similarly, Facchini et al. explored the effect of insulin on a variety of chronic 
conditions, and reported that insulin resistance significantly predicted risk for “age-related” 
disease in 208 healthy, nonobese subjects.  In this study “age-related disease” included coronary 
heart disease, cerebrovascular disease, hypertension, diabetes, and cancer. 66  Insulin resistance 
was evaluated using steady-state plasma glucose concentrations during a continuous infusion of 
insulin and glucose, and subjects were divided into tertiles based on insulin sensitivity.  Over a 
mean follow-up period of 6.7 years, the tertile with the highest insulin sensitivity did not develop 
any age-related disease, while development of disease was significantly higher in tertile with the 
lowest insulin sensitivity.  Collectively these data suggest that insulin is associated with the 
development of several chronic diseases, including heart disease, hypertension, diabetes and 
cancer. 
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2.3.2 Insulin and coronary artery disease 
The relationship between insulin and cardiovascular disease has been examined extensively.  
Nondiabetic patients with diagnosed coronary artery disease are reported to have both higher 
fasting insulin levels during an OGTT and greater insulin-stimulated glucose uptake during a 
euglycemic insulin clamp when compared to healthy subjects without coronary artery disease.67  
Fasting insulin is also associated with increased risk of cardiovascular disease.  In a group of 
nondiabetic men, Rubins et al. observed a 31% increased risk of a major CVD event among 
those in the highest quartile for fasting plasma insulin.11  Similarly, Després et al. reported that 
hyperinsulinemia was an independent risk factor for ischemic heart disease in a group of men 
age 35-64 who were free from heart disease at baseline.68  In this case-control study, fasting 
insulin was significantly associated with risk of ischemic heart disease; fasting insulin was 18% 
higher in the cases compared to controls at the end of a 12 year follow-up, and this association 
was independent of age, BMI, smoking status, lipids and alcohol use. 
Hyperinsulinemia may also contribute to development of more complex atherosclerotic 
lesions.  In non-diabetic and non-obese patients diagnosed with cardiovascular disease, fasting 
insulin and insulin response to an OGTT is associated with development of more complex 
atherosclerotic lesions.12  The escalated progression of atherosclerosis is one potential 
mechanism explaining the relationship between hyperinsulinemia and cardiovascular disease. 
While studies prior research demonstrates an association between fasting plasma insulin 
and heart disease, an even stronger relationship appears to exist between measures of insulin 
resistance and insulin response to a glucose load.  In a cohort from the Framingham Offspring 
Study, insulin resistance measured by the homeostasis model assessment formula (HOMA-IR) 
and the insulin sensitivity index (ISI0, 120) was significantly related to incident cardiovascular 
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disease over a median 6.7 year follow up period.69  Insulin levels two-hours following an OGTT 
may also predict cardiovascular disease.  In the San Antonio Heart Study, nondiabetic Mexican 
Americans and Non-Hispanic whites were followed for an average of 7.5 years. Increasing 
HOMA-IR scores were related to elevated risk of cardiovascular events, and this relationship 
remained significant after adjusting for other risk factors.10   Additionally, a meta-analysis 
examining 19 prospective studies concluded that there is a significant association between 
insulin and risk for coronary heart disease.70  The authors determined that the odds ratio for 
coronary heart disease was 1.35 with elevated non-fasting insulin, while the association between 
fasting insulin and heart disease risk was not significant.  Therefore, examining the insulin 
response to a glucose challenge may be more indicative of risk than only measuring fasting 
insulin. 
2.3.3 Insulin and cardiovascular disease risk factors 
The connection between insulin and cardiovascular risk factors may be related to presence of risk 
factors.  In particular, hyperinsulinemia and insulin resistance are associated with dyslipidemia 
and hypertension. Hyperinsulinemia is associated with low HDL-cholesterol and high plasma 
triglyceride concentrations,13 as well as increased concentrations of apolipoprotein B (apoB)71 
and small dense LDL particles.72-73  In a group of non-diabetic adults from the San Antonio 
Heart Study, fasting insulin and insulin during an OGTT were positively correlated with fasting 
triglyceride levels, and negatively correlated with HDL cholesterol and LDL particle size.73  The 
inverse relationship between hyperinsulinemia and LDL particle size remained significant after 
adjusting for age, gender, BMI, waist-to-hip ratio and levels of triglycerides, HDL cholesterol 
and fasting plasma glucose.  Garvey et al. reported similar results using insulin-stimulated 
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glucose disposal during a euglycemic clamp as a measure of insulin resistance.72  In both diabetic 
and non-diabetic patients, LDL particle size decreased as insulin resistance increased, and this 
relationship was significant after adjusting for age, sex, race and BMI.  In addition, Veerkamp et 
al. reported that subjects with familial combined hyperlipidemia (FCH) were significantly more 
insulin resistant as measured by HOMA,  compared to normolipidemic relatives.71  This 
relationship remained significant after adjusting for age, sex, and BMI.  Subjects with FCH also 
had greater apoB levels and greater presence of small dense LDL with increasing levels of 
insulin resistance.   
There also appears to be an association between insulin and development of 
hypertension.  In an early prospective study, Skarfors et al. observed that fasting insulin and 
insulin response to an intravenous glucose tolerance test (IVGTT) significantly predicted 
development of hypertension in a group of 1796 Swedish men.  In men who were normotensive 
at baseline, fasting insulin was 11.4% higher in men who developed hypertension over an 
average 10.2 year follow-up period.  Serum insulin 60-minutes following administration of 
glucose during an IVGTT was also 23.4% higher in the men who developed hypertension.  In a 
more recent cross-sectional study, approximately 50% of hypertensive adults were reported to be 
insulin resistant as measured by a modified insulin suppression test.74 
2.3.4 Insulin and nonalcoholic fatty liver disease 
NAFLD is another condition associated with hyperinsulinemia and insulin resistance.  Patients 
with NAFLD are more insulin resistant compared to individuals without liver disease.  
Marchesini et al. reported that fasting insulin and average insulin during an OGTT were 
significantly higher in NAFLD patients compared to age and sex-matched controls.75  Insulin 
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resistance was also the strongest predictor of NAFLD with an odds ratio of 15 (95% CI: 3.0-70) 
for each percent increase in HOMA-IR.  A recent prospective study by Rhee et al. suggests that 
elevated fasting insulin might predict development of NAFLD.15  In this study, fasting insulin in 
a group of non diabetic men and women of various BMI classifications was measured at baseline 
and again 5 years later. Subjects in the highest quartile for fasting insulin at baseline were at a 
significantly higher risk for developing NAFLD after five years, demonstrating that 
hyperinsulinemia may play a role in the pathogenesis of NAFLD. 
2.3.5 Insulin and polycystic ovarian syndrome 
Hyperinsulinemia and insulin resistance also contribute to the development of PCOS.76 Burghen 
et al. first observed the association between insulin resistance and PCOS in an early cross-
sectional study.77  In this study women with PCOS had higher fasting insulin levels and a greater 
insulin and glucose response during a three-hour OGTT compared to obese controls.  Insulin 
resistance appears to be independent of obesity in PCOS patients.  Dobrjansky et al. reported 
impaired insulin-stimulated glucose uptake during an insulin clamp in women with PCOS, and 
adjusting for obesity and total adiposity did not change this relationship.78 
2.3.6 Insulin and weight gain 
In addition to increased risk for the above health conditions, elevated insulin levels may 
contribute to weight gain or negatively impact weight management efforts.  The role of insulin is 
to facilitate glucose uptake for use and storage in tissues; thus, high levels may promote weight 
gain.  For example, diabetics treated with insulin therapy often experience weight gain.79-80 
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Several prospective studies have also observed an association between insulin levels and weight 
gain over time.  In a group of adults predisposed to diabetes, insulin levels following an OGTT 
predicted weight gain during an average 16.7 year follow-up period.17  Insulin may also predict 
weight gain in children.  In a group of Pima Indian children, fasting plasma insulin at baseline 
was significantly correlated with rates of weight gain and change in thickness of triceps skinfold 
thickness over a mean 9.3-year follow-up period.18  This relationship remained significant after 
adjusting for age, sex, initial weight and change in height. 
2.4 EFFECT OF EXERCISE ON INSULIN AND GLUCOSE 
Due to the health consequences associated with insulin resistance, it is important to further 
explore therapeutic methods to decrease circulating insulin and glucose levels.  Chronic exercise 
training is one such therapy which decreases insulin and glucose levels.  Acute exercise also 
affects insulin sensitivity, and a single bout of moderate-intensity aerobic exercise is associated 
with decreases in circulating glucose and insulin, and improvements in insulin stimulated 
glucose uptake.  
2.4.1 Effect of acute exercise on plasma insulin and glucose 
Decreased plasma insulin and glucose have been observed following a single exercise session in 
healthy, obese and diabetic populations.  Although insulin and glucose are not normally elevated 
in a healthy population, acute exercise still decreases these measures immediately post-exercise.  
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For example, a recent study reported a 5% decrease in glucose and a 10% decrease in insulin in 
healthy adults following 60-120 minutes of aerobic exercise at 60% VO2max.19 
The effect of acute exercise on plasma insulin and glucose has also been evaluated in 
obese and diabetic populations.  These two groups are characterized by hyperinsulemia, insulin 
resistance, and potentially hyperglycemia.  In an early study, Minuk et al. examined changes in 
fasting insulin and glucose following 45 minutes of aerobic exercise at 60% VO2max in obese 
diabetics and obese non-diabetics.81  Insulin decreased significantly from 0.90±0.15 ng/ml to a 
nadir of 0.65±0.09 ng/ml during exercise in the obese nondiabetic group, but no significant 
changes were observed in the obese diabetic group.  Fasting plasma glucose was elevated in the 
diabetics compared to the nondiabetics, but exercise did not significantly change glucose in 
either group.  Conversely, Martin et al. reported a significant decrease in glucose from 10.0±0.9 
mmol/L to 9.0±0.9mmol/L in diabetic subjects following 40 minutes of exercise at 60% 
VO2max.82  However, no change was observed in a lean, nondiabetic control group and insulin did 
not significantly decrease in either group. 
While results examining changes in fasting measures are conflicting, observations in 
studies measuring postprandial changes in insulin and glucose are more consistent.  Poirier et al. 
observed that sixty minutes of exercise at 60% VO2max decreased postprandial glucose from 
8.2±0.4 mmol/L to 6.0±0.2 mmol/L in a group of 19 men with type 2 diabetes and various BMI 
classifications.83  Larsen et al. also reported a decrease in postprandial glucose and insulin 
following both moderate22 and high-intensity exercise in diabetic men.84   Both a single session 
of moderate intensity exercise for 45 minutes and four sessions of high intensity exercise 
separated by six minutes of rest significantly decreased plasma insulin and glucose following a 
breakfast meal.  Moderate intensity exercise decreased the area under the curve (AUC)  for 
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glucose and insulin during an OGTT by 52% and 34%, respectively.22  Following the high 
intensity exercise, plasma glucose was decreased from 12.6±0.7 mmol/L to 11.4±0.8 mmol/L 
and insulin decreased from 144±27 pmol/L to 93±21 pmol/L.84   
Recently, van Dijk et al. reported a significant reduction in 24-hour average blood 
glucose values following a single aerobic exercise session.85  In this trial subjects with either 
impaired glucose tolerance or type 2 diabetes participated in 45 minutes of stationary cycling at 
50% of their maximum workload capacity at the beginning of a 24-hour observation period.  
Subjects were fed a standardized diet preceding and throughout the observation period.  All 
exercise sessions were performed 2.5 hours following breakfast, and blood glucose was 
measured using continuous glucose monitoring.   Average blood glucose was 7.4±0.2 mmol/L in 
the impaired glucose tolerance group during the control condition, and decreased to 6.8±0.2 
mmol/L when subjects exercised.  Similarly, average blood glucose was 9.6±0.5 and 9.2±0.7 
mmol/L during the control session in type 2 diabetics treated with oral medications and insulin, 
respectively; these values decreased to 8.6±0.5 and 8.5±0.5 mmol/L with the exercise session.  
Therefore, based on the current evidence it is possible that acute exercise may have a greater 
effect on insulin and glucose when performed in a postprandial state compared to a fasting state.   
2.4.2 Effect of acute exercise on insulin-stimulated glucose uptake 
Insulin-stimulated glucose uptake is also improved following exercise in an obese population. In 
an early study, Burstein et al. reported improved insulin action measured using a three-stage 
euglycemic clamp immediately following exercise in obese and diabetic individuals.  Subjects 
exercised for 60 minutes at a heart rate of 150-160 beats/minute.  Compared to a lean control 
group, insulin was elevated and glucose disposal was decreased in obese and diabetic 
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individuals.  Following the exercise session circulating insulin decreased and insulin-stimulated 
glucose uptake increased in the obese, nondiabetic group, but not the lean control group.  
Exercise increased the maximal clearance rate of glucose at the highest serum insulin 
concentration of the three stage insulin clamp by 124% in the obese diabetics and 134% in the 
obese group.   Cusi et al. observed similar results during a euglycemic insulin clamp performed 
24 hours following an acute exercise session.  Lean controls, obese nondiabetics, and diabetics 
each participated in 60 minutes of aerobic exercise at 65% VO2max.  Insulin-stimulated glucose 
disposal was improved in the obese non-diabetics, but not the diabetics.  In the obese 
nondiabetics, glucose disposal during the 90-120 min period of an insulin clamp improved from 
3.65±0.74 to 4.32±0.85 mg/kg/min following the 60-minute exercise session.  These findings 
suggest that exercise may be an important mechanism to decrease insulin response and improve 
insulin action in an obese population. 
2.4.3 Time course for changes in insulin following acute exercise 
While acute exercise improves insulin sensitivity following exercise, this effect is transient.   A 
single bout of exercise has been shown to increase insulin sensitivity for a period of two to 72 
hours following the exercise session.23-25   King et al. examined the time course of improved 
insulin sensitivity in a group of healthy, trained men and women following five consecutive days 
of aerobic exercise training.  An OGTT was performed on days one, three, five and seven 
following the final exercise session.  On days one and three the insulin AUC in response to a 
glucose load was significantly lower.  By days five and seven, no differences in the insulin AUC 
after an OGTT were observed compared to baseline.  Similar responses were reported in a cohort 
from the HERITAGE family study.  Following 20 weeks of aerobic exercise training, fasting 
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insulin significantly decreased by 8% in the 24 hours following an exercise bout, but returned to 
baseline 72 hours post-exercise.25  Thus, insulin sensitivity following exercise is transient, even 
in a trained population.  While current research suggests the effect of exercise does not last 
longer than 72 hours, there is currently limited evidence regarding the specific time course of 
changes in insulin, particularly in an obese population. 
2.4.4 Chronic effect of short bouts of exercise on insulin and glucose 
Current physical activity recommendations indicate that activity can be accumulated in bouts 
lasting a minimum of 10 minutes.26-28  Research suggests that accumulating physical activity in 
10-minute bouts effectively increases cardiovascular fitness29-36 and promotes weight loss.29-31  
These improvements are equivalent or superior to changes following continuous exercise 
training.  For example, Murphy et al. observed significant improvements in fitness between 
groups exercising once per day for 30 minutes and those performing three 10-minute bouts per 
day.  However, only the group performing short bouts significantly decreased body mass and 
waist circumference.  While fitness and are improved by accumulating short bouts of activity, the 
effect of these programs on other health outcomes such as insulin and glucose are not yet fully 
understood.   
Although there is limited research on the effectiveness of short bouts for decreasing 
insulin and glucose and improving insulin resistance, current exercise recommendations for 
obese28 and diabetic adults24 suggest performing short bouts to meet daily activity requirements.  
It is possible that performing activity in short bouts improves insulin and glucose as effectively 
as exercising for one continuous session. However, few studies have explored this question and 
current findings are equivocal. 
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In one study, Donnelly et al. examined the effect of 18 months of intermittent versus 
continuous exercise training on metabolic variables, including insulin and glucose in overweight 
or obese females.32  The continuous group performed 30 minutes of exercise at 60-75% VO2max 
three times a week. The intermittent group exercised twice a day, five days per week at 50-65% 
heart rate reserve (HRR). 18 months of training significantly decreased fasting insulin in the 
intermittent exercise group only, while insulin AUC during a two-hour OGTT decreased in both 
groups.  Fasting insulin decreased from 15.81±14.95 μU/mL to 11.90±9.38 μU/mL.  There were 
no changes in fasting glucose or glucose during the OGTT in either group following exercise 
training.  Conversely, Eriksen et al. reported the opposite effect for insulin and glucose in a 
group of 18 overweight or obese diabetic adults.37  Subjects performed 30 minutes of aerobic 
exercise training, six days per week at 60-65% VO2max.  Exercise was performed either in one 
continuous 30-minute bout or three 10-minute bouts throughout the day.  Following five weeks 
of training, fasting glucose decreased by 0.5 mmol/L and glucose AUC during an OGTT 
decreased by 7.5% in the intermittent exercise training group only. No changes were seen in 
insulin measures for either exercise group.  
While the changes observed in insulin and glucose following intermittent exercise 
training are inconsistent, these differences may be related to the population studied.  Donnelly et 
al. reported changes in insulin but not glucose in a group of overweight or obese females.  
However, glucose but not insulin was decreased in the diabetic subjects studied by Eriksen et al.  
It is possible that these conflicting findings are related to differences in insulin and glucose levels 
between populations based on the degree of insulin resistance present.  As discussed previously, 
in the early stages of insulin resistance increased insulin secretion overcomes hyperglycemia and 
maintains normal glucose levels.  As insulin resistance progresses to diabetes, insulin secretion is 
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impaired and hyperglycemia results.   Therefore, an obese nondiabetic population as studied by 
Donnelly et al. may demonstrate larger changes in insulin with exercise, while blood glucose 
may be affected to a greater degree than insulin in diabetic subjects.  Due to the limited data and 
differences observed between obese and diabetic adults, it is important to further explore the 
effect of exercise on changes in insulin and glucose in these populations.  
2.4.5 Acute effect of short bouts of exercise on insulin and glucose 
The literature regarding the acute effect of accumulating short bouts of exercise on changes in 
insulin and glucose is limited, and most studies have been performed in healthy adults.  For 
example, Goto et al. examined the effect of either one continuous 60-minute exercise session 
compared to two 30-minute sessions separated by a 20 minute rest period in eight healthy, 
physically active men.86  All exercise sessions were performed at 60% VO2max.  Plasma insulin 
and glucose were collected at 15-minute intervals during and after the exercise sessions.  During 
the exercise sessions both insulin and glucose were significantly lower in the second half of the 
repeated exercise trial compared to the single exercise trial.  During the second half of the 
exercise session insulin was significantly lower in the repeated exercise session (1.8±0.3μU/ml) 
compared to the continuous session (2.9±0.4μU/ml).  In the repeated exercise trial, glucose 
decreased from 89±2 mg/dL to 83±1 mg/dL, during the second half of the exercise session. 
However, there were no differences between exercise sessions observed in recovery for insulin 
or glucose.  
Changes in insulin and glucose following short bouts of exercise have also been observed 
in healthy subjects when measured the morning after an exercise session.  In an early study, Gill 
et al. had 18 healthy males run at 60% of VO2max for a single 90-minute session, three 30-minute 
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sessions spread throughout the day, and a control session with no exercise.38  The next morning, 
subjects were given a high-fat meal (1.2 g fat, 1.2 g carbohydrate, 70 kJ/kg body weight) and 
blood samples were obtained hourly for a six hours.  No differences in fasting insulin were 
observed between the two exercise treatments, while insulin AUC was lower following short 
bouts compared to the control condition.  There were no changes reported in fasting glucose or 
glucose AUC in the continuous session.  Miyashita et al. recently reported similar results.39  In 
this study, ten healthy, recreationally active men participated in either three 10-minute sessions 
with 30 minutes of rest in between, or a single 30-minute session.  All exercise sessions were 
performed at 70% VO2max.  The next day subjects consumed a mixed meal (56% fat, 33% 
carbohydrate, 11% protein, 46 kJ/kg body weight) for breakfast and lunch.  The meals were 
consumed three hours apart and blood was sampled each hour for a 7-hour period.  In 
concordance with the results from Gill et al.,38 postprandial plasma insulin AUC was 
significantly  lower following the meals after performing multiple short bouts of activity 
compared to the continuous exercise session.  There were no changes in fasting insulin, glucose, 
or glucose response to the test meals in any of the experimental conditions. 
 While multiple short bouts of exercise appear to have an acute effect on postprandial 
insulin levels in a healthy population, there is limited data in obese or diabetic populations.   A 
recent study explored the effect of 60 minutes of aerobic exercise performed on a single day, 
compared to two 30-minute sessions performed on consecutive days in a group of male type 2 
diabetics.87  Each subject participated in a control condition, 30 minutes of exercise performed 
on two consecutive days, and 60 minutes of exercise performed in a single bout.  All exercise 
sessions consisted of stationary cycling at a 50% of maximum workload, and were performed 1.5 
hours following a breakfast meal. Subjects were fed a standardized diet during the 48-hour 
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observation period and blood glucose was measured using continuous glucose monitoring.  
Additional blood draws were performed before breakfast in the fasting state and 2.5 hours after 
breakfast.    Both 30 and 60 minutes of exercise significantly lowered plasma insulin and glucose 
in a dose-dependent manner 2.5 hour following breakfast. However, there was no difference in 
fasting insulin or glucose between the 60-minute and a 30-minute session the following morning.  
At the 2.5 hour post-breakfast blood draw on the second day, postprandial glucose was 
significantly lower than the control after performing the single 60-minute session the previous 
day and the second 30-minute session that morning.  However, the 30-minute exercise performed 
that morning produced a significantly greater effect.  Postprandial insulin was only significantly 
decreased when 30 minutes had been performed that morning, and there was no effect from the 
60-minute session performed the prior day. These results suggest that performing shorter 
duration exercise on multiple days may be as effective as one day of continuous exercise for 
controlling insulin and glucose in type 2 diabetics, as long as energy expenditure is equivalent.   
   Currently, only one study has examined the effect of accumulating activity in short bouts 
in nondiabetic adults.  Murphy et al. recruited 10 apparently healthy men and women with BMI 
< 35 kg/m2; BMI classification ranged from 23.9 kg/m2 to 34.5 kg/m2.  Subjects participated in 
one 30-minute exercise session before breakfast, or a 10-minute session before breakfast, lunch 
and dinner.  All exercise sessions were performed at 60% VO2max.  Blood samples were collected 
throughout the entire day, and there were no changes in insulin or glucose observed at any 
timepoint in either session.  This is currently the only study examine look at the effect of short 
bouts of exercise on insulin and glucose in obese subjects, with BMI ranging from normal weight 
to obese, making these findings difficult to generalize to an obese population. 
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2.4.6 Gaps in the literature 
Several studies have examined the effect of exercise on changes in insulin and glucose.  
However, there are methodological differences in the measurement of insulin and glucose 
(fasting, response to an OGTT, euglycemic insulin clamp) between these studies, making it 
difficult to interpret the results.  Additionally, the populations included in the current research 
include healthy, obese and diabetic individuals.  These groups vary with regards to severity of 
insulin resistance, and subsequent response to insulin and glucose.  Therefore, it is not possible 
to generalize the findings between the groups. 
The literature is limited regarding the effectiveness of short bouts of activity for 
improving plasma insulin and glucose in an obese population.  Data from exercise training 
studies suggest that accumulating short bouts of activity may result in lower insulin response to a 
glucose load in an obese population.  In normal weight and diabetic populations, exercise 
appears to decrease postprandial insulin.  In an obese population, exercise before a meal may not 
significantly decrease insulin and glucose, but the effect of exercise on insulin and glucose when 
performed in the postprandial state is currently unknown in this population.  Therefore, the 
purpose of this study is to examine the postprandial effect of insulin and glucose in response to a 
10-minute and a 30-minute exercise session in obese adults. 
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3.0  METHODS 
It is currently estimated that approximately one-third of the U.S. adult population is obese.1 
Obesity is associated with increased risk of multiple chronic diseases.2 It has been suggested that 
hyperinsulinemia accompanying insulin resistance is the central risk factors connecting obesity 
to the increased development of health complictations.5, 13 
 An acute exercise session is associated with decreases in plasma insulin and glucose.  
Current exercise prescription guidelines suggest that exercise can be performed in multiple short 
bouts, but it is unknown how shorter exercise sessions affect insulin and glucose compared to a 
single, longer exercise session.  The aim of this study was to examine the effect of a 10-minute 
bout of exercise compared to a 30-minute bout on changes in postprandial insulin and glucose.  
This was done to better explain if performing short bouts of exercise may have an equal or better 
effect on decreasing insulin and glucose in an obese population. 
3.1 SUBJECTS 
A total of 11 apparently healthy men and women between the ages of 35-55 were recruited to 
participate in this study.  Subjects were Class I, Class II, or Class III Obese according to BMI 
classification (30.0-<45.0 kg/m2), and were sedentary defined as exercising at a moderate-
intensity less than 60 minutes per week over the last six months.   
 42 
Additional exclusionary criteria for this study included:  
1) Previous diagnosis of cancer, heart disease, Type I or Type II diabetes, or polycystic 
ovarian syndrome.  Individuals with these conditions require medical clearance that 
was beyond the proposed scope of this study.28  Additionally, the response of glucose 
and insulin in individuals with diabetes and polycystic ovarian syndrome may be 
altered and may affect measures of the primary outcomes (i.e., insulin and glucose). 
2) Taking prescription or over-the-counter medications that affects glucose metabolism, 
insulin, blood pressure or heart rate.  Medications that alter glucose metabolism or 
insulin (such as thiazolidinediones, oral glucocorticoids, nicotinic acid, and oral 
steroids) may alter how these variables respond to exercise.  Subjects were asked to 
perform a submaximal graded exercise test to 85% of age-predicted maximal heart 
rate, and medications altering heart rate affect the ability to determine termination 
heart rate during this test.  Additionally, the intensity of exercise during testing 
sessions was determined using heart rate, and medications altering heart rate would 
affect the ability to determine appropriate exercise intensity.    
3) Presence of any condition that may limit one’s ability to walk for exercise (e.g., 
orthopedic limitations or severe arthritis).  Subjects were required to walk for exercise 
to complete the sub maximal graded exercise test and subsequent testing sessions, and 
any orthopedic limitations would limit the ability of these individuals to complete 
these components of this study. 
4) Currently participating in a weight loss program or reporting significant weight loss 
(>3.0% of body weight) in the past month.  Changes in weight have been shown to 
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influence glucose metabolism and insulin, and subjects were asked to maintain their 
current body weight during their participation in the study.88-90  
5) Women who were pregnant at any point during the study.  Vigorous exercise is not 
recommended for women who are pregnant, which would limit the ability of these 
women to participate in the graded exercise test in this study.28  Pregnancy also 
affects glucose and insulin levels,91-92 which would influence the main outcome 
measures of the study. 
6) A resting systolic blood pressure of ≥140 mmHg or a diastolic blood pressure of ≥90 
mmHg or currently taking prescription medication to control blood pressure.    Blood 
pressure at these levels or currently taking medication to control blood pressure 
contraindicates participation in a submaximal graded exercise test without the 
supervision of a physician.28  Therefore, blood pressure at these levels posed a safety 
concern in this study. 
7) Premenopausal women who reported irregular menstrual cycles (<25 days or >35 
days between cycles).  Hormonal variations during the menstrual cycle affect glucose 
and insulin levels,93-94 thus all premenopausal female subjects were tested during days 
1-14 of the menstrual cycle.  If premenopausal women do not have regular menstrual 
cycles it impaires the ability to schedule them so that testing sessions could occur 
during this period of time. 
8) Report consuming more than a moderate amount of alcohol (>7 drinks per week for 
females and >14 drinks per week for males)95  Alcohol consumption affects blood 
glucose levels, and excess consumption would affect glucose levels during the testing 
sessions. 
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3.2 RECRUITMENT AND SCREENING PROCEDURES 
Subjects were recruited through local flier postings and Craigslist advertisements. Additionally, 
letters were mailed to individuals meeting eligibility requirements registered in the Obesity and 
Nutrition Research Center (ONRC) database.  The University of Pittsburgh Institutional Review 
Board (IRB) approved all recruitment methods and materials. Interested individuals were 
instructed to call the University of Pittsburgh Physical Activity and Weight Management 
Research Center (PAWMRC).  Trained staff and graduate students at the PAWMRC read a 
description of this study and delivered a brief phone screening to participants who provided 
verbal consent.  Screening information included questions regarding demographic background, 
physical health and medical history to determine initial eligibility.   
Individuals who were found to be eligible following the phone screening were invited to 
attend an orientation session conducted by the Principle Investigator (PI).  During this orientation 
the PI reviewed the study protocol and gave individuals an opportunity to answer any questions 
before signing an informed consent document.  Subjects also completed a Physical Activity 
Readiness Questionnaire (PAR-Q)96 to ensure that participation in exercise was not 
contraindicated.  Eligible subjects then underwent an initial assessment and three experimental 
sessions as described below.  The IRB at the University of Pittsburgh approved all study 
procedures. 
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3.3 ASSESSMENT PROCEDURES 
3.3.1 Height 
Height was measured using a wall-mounted stadiometer (Perspective Enterprises; Portage MI).  
The subject removed their shoes and stood erect on the floor with his/her back parallel to the 
vertical mounted measure scale, looking straight ahead.  The subject was instructed to stand as 
straight as possible with feet flat on the floor.  The horizontal measuring block was brought 
down snugly, but not tightly, on top of the head.  Height was recorded to the nearest 0.1 cm. 
3.3.2 Body weight and body mass index 
Body weight was measured using a Tanita WB-110A digital scale (Tanita Corporation; 
Arlington Heights, II).  Measurements were made with subjects wearing a lightweight hospital 
gown with shoes removed.  Weight was recorded to the nearest 0.1kg. BMI was computed based 
on measurements of weight and height and was calculated as body weight in kilograms divided 
by square height in meters (kg/m2). 
3.3.3 Resting seated heart rate and blood pressure 
Resting blood pressure and heart rate was assessed using a DINAMAP V100 (GE Healthcare) 
automated blood pressure system. Cuff size was determined by arm circumference. Each of the 
following cuff sizes was available: Adult, Large Adult, Thigh and Long Large Adult.  A Gulick 
Tape Measure was used for measurement of the participant’s arm circumference.  Arm 
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measurement was performed on the lateral aspect of the arm at the midpoint between the 
acromion process to the olecranon process. The cuff size was determined from the arm 
circumference measurement according to the following chart: 
Arm Circumference Cuff Size 
17.0 to <24.0 cm Small Adult 
24.0 to <33.0 cm Adult 
33.0 to <41.0 cm Large Adult 
>41.0 cm Thigh or Large Adult Long* 
*(If a participant’s upper arm circumference indicated use of the thigh cuff, but the arm was too 
short for the cuff, or the cuff did not remain secured when inflated, the Large Adult Long arm 
cuff was used.) 
 
Blood pressure was measured with subjects seated and both feet flat on the floor.  
Subjects rested quietly for a five-minute period prior to the first measurement.  A second 
measurement was taken following a minimum 60-second waiting period.  A third measurement 
was obtained if the two systolic blood pressures differ by ≥10 mm Hg or the diastolic blood 
pressures differed by ≥6 mm Hg. 
 The Dinamap automated blood pressure system also provided a measure of heart rate.  
Thus, resting heart rate was measured simultaneously with the measures of resting blood 
pressure as described above. 
3.3.4 Waist circumference 
A Gulick Tape Measure was used for obtaining waist girth measurements.  All measurements 
were taken with the subject in a lightweight hospital gown.  Waist circumference was measured 
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horizontally at the iliac crest. To determine the level at which waist circumference was measured 
the examiner faced the subject and palpated the upper hip bone to locate the iliac crest.  The 
subject then placed their fingertips directly above the iliac crest and the examiner placed the 
measuring tape around the abdomen directly below the fingertips.  Duplicate measurements were 
taken at the end of a normal exhalation measurements were recorded to the nearest 0.1cm.   A 
third measurement was taken if the two measures differed by ≥1.0 cm. 
3.3.5 Graded exercise test 
Cardiorespiratory fitness was evaluated using a submaximal graded exercise test utilizing a 
protocol developed for the Look AHEAD study.97  The speed of the treadmill was kept constant 
at 3.0 mph (80.4 m/min) throughout the test.   The initial grade of the treadmill was set to 0% 
and increased at 1.0% increments each minute until the subject reached 85% of age-predicted 
maximal heart rate, determined by the equation:  220-age.  The metabolic cart (SensorMedics 
Vmax Metabolic Measuring Cart; SensorMedics; Yorba Linda, CA) was calibrated for air 
volume and gas analysis prior to each test.  A certified Clinical Exercise Specialist as recognized 
by the American College of Sports Medicine conducted all graded exercise tests.   
Prior to the test, subjects entered the testing room and were given a brief overview of the 
test protocol.  The exercise specialist explained the Borg 15-point Rating of Perceived Exertion 
Scale.98  PAWMRC staff then prepared the subject for the exercise test by cleaning the sites for 
each of the 12 leads with rubbing alcohol and placing electrodes over these sites.  The electrodes 
were then attached to the leads for 12-lead EKG monitoring.  The Exercise Specialist then 
obtained a seated resting EKG printout prior to beginning the test to assure that exercise was not 
contraindicated.   
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The subject was then fitted with the airflow mouthpiece and head support system before the test 
began.  The speed of the treadmill was set at 3.0mph (80.4 m/min) and remained constant 
throughout the test.  The initial grade was set to 0.0%.  Heart rate during exercise testing was 
obtained at one-minute intervals and immediately upon termination of the exercise test using 12-
lead ECG (Cardiosoft, SensorMedics; Yorba Linda, CA).  Blood pressure was obtained during 
each even minute (2 min, 4, min, 6 min etc.) and immediately upon termination of the exercise 
test.  Rating of perceived exertion was assessed immediately following blood pressure 
measurement and at the point of test termination.  Expired gas volumes and concentrations were 
measured continuously during the test to determine oxygen uptake and substrate utilization 
throughout the test.   The test was terminated when the subject reached 85% of their maximum 
heart rate or following any signs or symptoms indicative of test termination as described by the 
American College of Sports Medicine.  Following test termination, Subjects performed a three 
minute active recovery at 0% grade and 2.0-2.5% mph.  During the active recovery the airflow 
mouthpiece and head support system was removed.  Blood pressure was assessed during active 
recovery, and then the subject sat on a hospital bed to allow heart rate and blood pressure to 
return to resting values.  A board certified cardiologist evaluated the results of all tests to ensure 
that exercise was not contraindicated.  All testing staff and personnel were certified in 
cardiopulmonary resuscitation (CPR) and use of the Automated External Defibrillator (AED), 
and safety equipment was readily accessible in the testing room. 
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3.4 EXPERIMENTAL DESIGN 
Eligible subjects reported to the PAWMRC for three separate experimental sessions following 
the initial assessment visit.  These included a 10-minute exercise testing session (10-EX), a 30-
minute exercise testing session (30-EX), and a sedentary testing session (REST).  Subjects were 
randomized using a counterbalanced design to complete these sessions.  All testing session 
occurred in the morning following a 12-hour fast.  Since hormonal changes throughout the 
menstrual cycle affect insulin and glucose,93-94 all premenopausal women were tested during 
days 1-14 of their menstrual cycle as determined by self-report.  All three testing sessions were 
performed within a 31 day time period. 
Prior to each experimental session subjects adhered to the following protocol:  1) 
refrained from exercise for 72 hours prior to the experimental session; 2) kept a detailed food 
record for one day prior to the experimental session; 3) avoided alcohol for 24 hours prior to the 
experimental session; 4) abstained from all food and drink other than water for 12 hours prior to 
the experimental session.  Prior to the first experimental session subjects recorded all food and 
drink consumed during the previous day, and this record was photocopied and returned to 
subjects.  Subjects were asked to replicate this food intake as closely as possible for the 
subsequent testing sessions to prevent differences in diet from influencing outcome measures. 
Compliance to these directions was verified via self-report prior to each experimental session.   
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3.5 EXPERIMENTAL SESSIONS 
Subjects reported to the PAWMRC on the morning of each experimental session.  Upon arrival 
the subject verified adherence to the protocol for pre-session directions as stated above.  The 
subject was weighed, fitted with a Polar Heart Rate Monitor (for the 10-EX and 30-EX 
conditions), and all testing procedures were reviewed. 
An initial blood draw to assess fasting glucose and insulin was then performed on each 
subject.  Subjects were then provided a standardized breakfast containing 20% of their estimated 
energy requirement, composed of 55% carbohydrate, 30% fat and 15% protein (See Appendix 
M).  This macronutrient distribution is within the range recommended by the U.S. Department of 
Agriculture and U.S. Department of Health and Human Service.95  Additionally, exercise has 
been shown to reduce blood glucose following a breakfast meal containing this macronutrient 
distribution.22   Estimated energy requirement was determined using the appropriate sex-specific 
Mifflin-St. Jeor equation to calculate resting energy expenditure and then multiplied by an 
activity factor of 1.2 for sedentary men or sedentary women.99  Subjects were given 15 minutes 
to consume the breakfast meal.  During the initial experimental session the time to consume the 
meal was recorded and then was replicated during subsequent experimental sessions.   
Subjects remained in the laboratory for a 120-minute testing period following the 
breakfast meal.  After consuming breakfast, subjects were asked to sit quietly for thirty minutes 
before another blood draw was performed.  Immediately following this blood draw, subjects 
participated in either ten minutes of exercise (10-EX condition), thirty minutes of exercise (30-
ex), or continued their resting period (REST condition).  The flow of these experimental sessions 
is outlined in figure 1, and details are described below: 
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30-EX Condition 
Breakfast meal 30 minute rest 
period 
30 minute 
exercise session 
30 minute rest 
period 
30 minute rest 
period 
 
 
 
 
 
 
10-EX Condition 
Breakfast 
meal 
30 minute 
rest period 
10 minute 
exercise 
session 
20 minute 
rest period 
30 minute 
rest period 
30 minute 
rest period 
 
 
 
 
 
REST Condition 
Breakfast meal 30 minute rest 
period 
30 minute rest 
period 
30 minute rest 
period 
30 minute rest 
period 
 
 
 
 
 
 
 
Figure 1: Flow of subjects through testing sessions 
 
10-EX Condition:  Subjects walked on a treadmill for 10 minutes at a speed of 3.0 mph 
and a grade that induced a heart rate between 70-75% of the subject’s age-predicted maximal 
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heart rate.  Grade was initially set using data available from the graded exercise test performed 
during the assessment visit.  Heart rate was monitored during the last 5 seconds of each minute, 
and grade was adjusted if the subject’s heart rate fell outside of the target heart rate range for two 
consecutive minutes using the following protocol: 1) if the heart rate was below the range of 
70% to 75% of age-predicted maximal heart rate the grade was increased by 1%, 2) if the heart 
rate was above the range of 70% to 75% of age-predicted maximal heart rate the grade was 
decreased by 1%.  If a grade of 0% elicited a heart rate greater than the target range the speed 
was decreased in 0.2 mph increments.   
Exercise was terminated at the end of ten minutes of walking.  Subjects then rested 
quietly for the remainder of the 120 minute testing period (80 minutes).  During this time, they 
were permitted to watch a video or read magazines provided by the investigator.   Subjects were 
also allowed to read materials or watch videos that were approved by the investigator.  Subjects 
were allowed to consume water ad libitum throughout the entire experimental condition.  
Subjects underwent blood draws every 30 minutes during the testing period following breakfast 
consumption, occurring at 30, 60, 90 and 120 minutes. 
30-EX Condition:  Subjects walked on a treadmill for 30 minutes at a speed of 3.0 mph 
and a grade induced a heart rate between 70-75% of the subject’s age-predicted maximal heart 
rate.  Selection of initial grade and any alterations to grade and/or speed occurred in an identical 
manner as described above for the 10-EX condition.  The only difference in the two exercise 
sessions was the length of time the subject walked on the treadmill.  Exercise was terminated 
following 30 minutes of walking.  Subjects then rested quietly for the remainder of the 120 
minute testing period (60 minutes).  During this time, they were permitted to watch a video or 
read magazines provided by the investigator.   Subjects were also allowed to read materials or 
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watch videos that were approved by the investigator.  Subjects were allowed to consume water 
ad libitum throughout the entire experimental condition.  Subjects underwent blood draws every 
30 minutes during the testing period following breakfast consumption, occurring at 30, 60, 90 
and 120 minutes. 
REST Condition:  Subjects were instructed to rest quietly in a seated, upright position 
for the 120 minute testing session.  During this time, they were permitted to watch a video or 
read magazines provided by the investigator.  Subjects were also allowed to read materials or 
watch videos that were approved by the investigator.  Every thirty minutes subjects underwent a 
blood draw, occurring at 30, 60, 90 and 120 minutes after the subject finished consuming the 
breakfast meal.  Subjects were allowed to consume water ad libitum during the entire testing 
session. 
3.6 PRIMARY OUTCOME MEASURES 
Insulin and Glucose were analyzed at the Heinz Laboratory using the following procedures. 
Insulin:  Insulin was measured using an RIA procedure developed by Linco Research, 
Inc.  Cross-reactivity of the antibody with human proinsulin is under 0.2%.  Briefly, samples 
were mixed with 125I-insulin and insulin antibody and then incubated at room temperature for 18 
to 24 hours.  The insulin-antibody complex was precipitated during a 20 minute incubation at 4 
degrees C and subsequently sedimented by centrifugation for 15 min at 3,000g at 4 degrees C.  
Finally, the supernatant was decanted and the pellets were counted.  Under these conditions the 
limit of sensitivity is 2 μU/ml and the response is linear up to 200 μU/ml.  Standards, blanks, 
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quality controls and commercial serum control pools were run simultaneously with all samples.  
The coefficient of variation between runs is 8.2 +/- 0.7 (170)%.  The intra assay CV% is 7.0 %. 
Glucose:  Serum glucose was quantitatively determined using an enzymic determination 
read at 340/380 nm, utilizing the coupled enzyme reactions catalyzed by hexokinase and 
glucose-6-phosphate dehydrogenase.  Using the Sigma Diagnostics glucose [HK] 20 reagent, 
serum was diluted 1:101.  The mixture was then incubated for four minutes at 37°C and read at 
340/380 nm using the Abbott VP Supersystem spectrophotometer.  The increase in absorbance at 
340/380 nm is directly proportional to the glucose concentration of the sample.  The coefficient 
of variation between runs is 2.0%.  The intra assay coefficient of variation is 1.6%. 
 
3.7 STASTICAL ANALYSIS 
Statistical analysis was performed using PASW software.  Statistical significance was set at p< 
0.05.  Descriptive analyses were performed for subject’s height, weight, BMI, blood pressure, 
waist circumference, VO2peak,  and average fasting insulin and glucose. 
To examine specific aims 1 and 2, separate one-way repeated measures analysis of 
variance (ANOVA) were performed on AUC for insulin and glucose across treatment conditions.  
AUC was calculated using the trapezoidal method.  The assumption of normality was tested 
using the Shapiro-Wilk test and assumption of sphericity was tested using Mauchly’s test.  If the 
assumption of sphericity was not met the Greenhouse-Geisser was used.  For variables that were 
not normally distributed the equivalent nonparametric tests were performed.   When necessary, 
post hoc comparisons were made using the Bonferonni adjustment to determine which variables 
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were significantly different. A one-way repeated measures ANOVA was also performed on both 
insulin AUC above fasting AUC, and glucose AUC above fasting AUC. 
  As exploratory analyses, a one-way ANOVA was performed on each time point across 
the three conditions, and for the change in insulin and glucose from fasting at each time point.  In 
addition, correlations between energy expenditure and insulin and glucose AUC were examined.  
Data for energy expenditure was not normally distributed and Spearman rank correlations were 
performed.  Partial correlations adjusting for body weight and fitness were analyzed. 
3.8 POWER ANALYSIS 
The aim of this study was to determine the change in insulin and glucose following 10-minutes 
of aerobic exercise, 30-minutes of aerobic exercise, or during a resting control period.  Previous 
research examining area under the curve for postprandial changes in insulin and glucose 
following  45 minutes of exercise report an effect size of r=0.85 for glucose and r=0.55 for 
insulin.22  This study examined exercise of shorter duration (30 minutes and 10 minutes) and it 
was anticipated that a smaller effect size would be observed.  Therefore it seemed reasonable to 
estimate a moderate effect size of r=0.50 for this study.  Using power of 0.70 and alpha of 0.05, 
25 subjects were needed to detect an effect size of 0.5. 
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4.0  RESULTS 
The purpose of this study was to examine the postprandial effect of insulin and glucose in 
response to a 10-minute and a 30-minute exercise session in obese adults.  This study utilized a 
randomized cross-over design and the results from the study are presented in the following 
sections. 
4.1 SUBJECTS 
A total of 21 obese men and women attended a study orientation and consented to participate in 
this study (Figure 2).  Six individuals failed to either schedule or attend the assessment, and 4 
were discovered to be ineligible at the assessment period.  11 obese men and women (mean 
BMI: 34.4 kg/m2) completed the assessment and were eligible to initiate experimental sessions.  
However, two subjects did not complete the experimental sessions due to an inability to obtain 
blood during the initial blood draw and did not proceed further with the experimental sessions.  
Thus, data were collected on a total of 9 subjects (Figure 2). Descriptive statistics (mean ± 
standard deviation) are shown in Table 1.   
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Figure 2 Subject recruitment and enrollment 
 
    
Contacted 
n=150 
Performed telephone screening 
n=112 
38 Did not complete phone screening 
19 – Evidence of exclusionary criteria before 
screening conducted 
19- Not interested based on description 
82 Did not meet Inclusion/Exclusion 
Criteria 
Eligible based on telephone screening 
n=30 
Consented to participate 
n=22 
8 Did not consent to participate 
6 – Failed to attend orientation 
1 – Unable to participate based on schedule 
1 – Ineligible at orientation 
Eligible to begin experimental session 
n=11 
11 Did not complete assessment 
2 – Ineligible based on irregular menstrual cycle 
1 – Elevated BP at assessment 
1 – Outside of BMI range at assessment 
5 – Not interested in participating further 
2 – Failed to attend assessment 
Completed all 3 experimental sessions 
n=9 
2 Stopped participation due to inability to 
obtain blood 
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Table 1 Descriptive variables (mean ± standard deviation) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Average from fasting values across all three experimental conditions (REST, 10-EX and 30-
EX) 
4.2 EXPERIMENTAL SESSIONS 
All subjects were able to successfully complete both the 10-minute and 30-minute bouts of 
treadmill walking during the experimental testing sessions.  Heart rate was recorded at the end of 
each minute during the 10-minute and 30-minute exercise sessions, and then averaged for each 
exercise session.  Subjects were able to walk at a speed and grade that elicited an average of 
72±3.5% and 73±1.8% of age-predicted maximal heart rate for the 10-EX and 30-EX sessions, 
 All Participants (n=11) 
Completers 
(n=9) 
Age (years) 46.0 ± 5.4 45.3 ± 5.7 
Height (cm) 170.0 ± 9.9 169.7 ± 11.0 
Weight (kg) 99.3 ± 13.8 96.7 ± 12.5 
BMI (kg/m2) 34.4 ± 3.7 33.6 ± 3.2 
Systolic Blood Pressure 
(mm/Hg) 122.2 ± 8.6 122.0 ± 8.8 
Diastolic Blood 
Pressure (mm/Hg) 73.9 ± 8.6 73.0 ± 8.9 
Waist Circumference 
(cm) 110.7 ± 11.5 107.7 ± 8.3 
VO2 peak (ml/kg/min) 24.8 ± 6.3 25.4 ± 6.8 
Average fasting plasma 
insulin* (μU/ml) 18.1 ± 7.9  18.1 ± 7.9  
Average fasting plasma 
glucose* (mg/dl) 102.0 ± 13.2 102.0 ± 13.2 
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respectively.  A repeated measures ANOVA demonstrated that the average heart rates during the 
10-EX and 30-EX exercise sessions were not significantly different (Table 2).   
Table 2 Differences in average heart rate across exercise conditions 
 10-EX Session (n = 9) 
30-EX Session 
(n = 9) P-Value 
Average Heart Rate 
(bmp) 125 ± 6.0 127 ± 3.5 0.204 
(Values presented at mean ± standard deviation) 
 
A repeated measures ANOVA revealed that body weight was not significantly different 
between the three experimental sessions (Table 3).  Additionally, a repeated measures ANOVA 
demonstrated that fasting insulin and glucose were not statistically different between 
experimental sessions (Table 3). 
Table 3 Differences in fasting weight, insulin and glucose across experimental conditions 
 REST Session 
(n = 9) 
10-EX Session 
(n = 9) 
30-EX Session 
(n = 9) P-Value 
Fasting Weight 
(kg) 97.5 ± 12.6 97.3 ± 12.6 97.5 ± 12.0 0.894 
Fasting Plasma 
Insulin (μU/ml) 17.0 ± 7.5  17.5 ± 9.2 20.0 ± 9.5 0.340 
Fasting Plasma 
Glucose (mg/dl) 103.7 ± 14.0 102.6 ± 11.5 99.7 ± 16.0 0.310 
(Values presented at mean ± standard deviation) 
4.3 COMPARISON OF PLASMA INSULIN AND GLUCOSE ACROSS 
CONDITIONS 
Separate one-way repeated measures ANOVAs were used to assess differences in total plasma 
insulin AUC and total plasma glucose AUC across the three treatment conditions. Four subjects 
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were missing a blood sample for at least one time point and were excluded from the AUC 
analysis.  The AUC analysis for plasma insulin and glucose was performed on the 5 subjects 
with complete data. There was no significant difference in plasma insulin AUC between the 
REST (12,270±6,148), 10-EX (10,633±5,162), and 30-EX (11,479±4,810) conditions (p=0.354) 
(Figure 3).  The effect size, calculated by Cohen’s d, was 0.3 for 10-EX compared to REST, and 
0.1 for both REST and 10-EX compared to 30-EX.  Similarly, there was no significant difference 
in plasma glucose AUC between the REST (23,184±6,023), 10-EX (21,735±2,680), and the 30-
EX (22,899±3328) conditions (p=0.554) (Figure 4).  The effect size for both REST and 30-EX 
compared to 10-EX was 0.2, and the effect size for REST compared to 30-EX was 0.0. 
 
Figure 3 Plasma insulin AUC for each experimental condition (mean ± standard deviation) 
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Figure 4 Plasma glucose AUC for each experimental condition (mean ± standard deviation) 
 
To correct for the potential confounding of fasting levels across the three conditions, 
AUC was also calculated for plasma insulin and glucose by subtracting the AUC below the 
fasting value (FAST) from the AUC above the fasting value for each condition.  For plasma 
insulin AUC above FAST (Figure 5), there were no significant differences between the three 
treatment groups (p=0.182).  There were also no significant differences between REST, 10-EX 
or 30-EX for glucose AUC above FAST (p=0.286) (Figure 6).   
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Figure 5 Plasma insulin AUC above FAST (mean ± standard deviation) 
 
 
Figure 6 Plasma glucose AUC above FAST (mean ± standard deviation) 
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and 8).  A one-way repeated measured ANOVA was performed on each time point for plasma 
insulin and plasma glucose across treatment conditions.   Following the breakfast meal, insulin 
increased similarly from FAST to the 30-minute post breakfast (30-MIN) time point across all 
three treatment conditions (p=0.72).  In the REST condition insulin peaked at 60-minutes post 
breakfast (60-MIN), but was lower in the 10-EX and 30-EX conditions.  A main effect for 
condition was observed at 60-MIN (p=0.018), but post-hoc analysis using pairwise comparisons 
with a Bonferroni adjustment did not reveal any significant differences between conditions.  
From 60-MIN to 90-minutes post breakfast (90-MIN), insulin decreased in REST while a 
rebound was observed in 30-EX; at 90-MIN there was no significant difference between 
conditions (p=0.235).  Insulin continued to decrease in all groups until 120-minutes post 
breakfast (120-MIN).  Insulin was significantly higher at 120-MIN in 30-EX compared to REST 
(p=0.042) 
A similar pattern was observed for plasma glucose during the three conditions.  Glucose 
increased in all three conditions following breakfast at 30-MIN (p=0.642), and began to decrease 
in all conditions at 60-MIN (p=0.227).  A rebound effect was observed for the 30-EX condition 
and glucose increased at 90-MIN; however, this pattern was not observed in REST or 10-EX.  A 
significant main effect for condition was observed at 90-MIN (p=0.037), but no differences 
between groups were detected in post-hoc analyses using pairwise comparison with a Bonferroni 
adjustment.  Glucose decreased in all three groups at 120-MIN similarly in all three conditions 
(p=0.278) 
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*Significant main effect for condition 
#30-EX significantly different from REST 
 
Figure 7  Pattern of change in plasma insulin across experimental conditions (data is presented for subjects 
with complete data only) 
 
 
*Significant main effect for condition 
 
Figure 8 Pattern of change in plasma glucose across experimental condition (data is presented for subject 
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Table 4 Insulin and glucose at each time point and by experimental condition (data is presented for subjects 
with complete data only) 
 Experimental Condition (n=5)  
Variable Time REST 10-EX 30-EX P-value 
Plasma 
Insulin 
(μU/ml) 
FAST 17.7 ± 9.4 20.2 ± 11.0 24.1 ± 10.2 0.279 
 30-MIN 72.3 ± 37.3 70.6 ± 32.3 92.3 ± 47.6  0.72 
60-MIN 94.9 ± 48.0 66.8 ± 30.3 32.3 ± 12.3 0.018
 A 
90-MIN 75.1 ± 41.8   70.2 ± 40.2 89.6 ± 38.3 0.235 
120-MIN 55.4 ± 45.7  45.6 ± 22.7 74.3 ± 45.2B 0.045
 A 
Plasma 
Glucose 
(mg/dl) 
FAST 110.4 ± 15.4 110.4 ± 7.5 106.6 ± 16.4 0.642 
 30-MIN 145.6 ± 34.8 134.0 ± 22.9 142.6 ± 26.4 0.138 
60-MIN* 138.6 ± 47.4 116.8 ± 14.6 106.8 ± 8.5 0.102 
90-MIN 121.4 ± 38.0 122.2 ± 21.5 147.6 ± 29.0 0.037
 A 
120-MIN 108.0 ± 24.0 109.2 ± 11.2 122.4 ± 30.5 0.278 
(Data is presented as mean ± standard deviation) 
A Significant difference among experimental conditions (p<0.05) 
B Significantly different compared to the REST condition 
*Variables were not normally distributed.   The main effect for condition was determined made 
using Friedman’s test.  
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4.4 DIFFERENCES IN CHANGE IN INSULIN AND GLUCOSE FROM FASTING 
A one-way repeated measures ANOVA was performed for the change in insulin and glucose 
from fasting at each time point across all three treatment differences (Table 5).  All available 
data was included for each time point.  A significant difference between groups was detected for 
plasma insulin at 60-MIN (p=0.002).  Post-hoc analysis revealed that the change in plasma 
insulin from fasting to 60-MIN was significantly lower in 30-EX (6.1±8.4) compared to both 10-
EX (38.3±22.0; p=0.029) and REST (67.4±36.8; p=0.026).  There was no significant difference 
in plasma insulin change between REST and 10-EX for any time points. 
 Change in plasma glucose from fasting was significantly different across treatment 
groups at 90-MIN (p=0.003) and 120-MIN (p=0.028) with a trend observed at 60-MIN 
(p=0.074).  Post hoc analysis determined that the change in plasma glucose at 90-MIN from 
fasting was significantly lower in REST (6.89±22.4; p=0.011) and 10-EX (6.1±18.1; p=0.031) 
compared to the 30-EX condition (31.6±21.3).  At 120-MIN, change in plasma glucose from 
fasting was also significantly lower in REST (-2.5±20.5; p=0.043) and 10-EX (-1.23±7.1; 
p=0.043) compared to the 30-EX condition (14.9±17.0).    There was no significant difference in 
plasma glucose change between REST and 10-EX for any time point. 
 Similar results were observed when analyzing the data by those with complete data only 
for each time point (Table 4), or when using all available data at each time point expressed as a 
change from the fasting value (Table 5); discrepancies were observed at only two time points.  
Specifically, both analyses detected a significant main effect for condition at the 60-MIN time 
point for plasma insulin and the 90-MIN time point for glucose.  However, at the 120-MIN time 
point for insulin, a significant main effect for treatment was observed only for the analysis on 
those with complete data.  Conversely, a significant main effect for condition was detected at the 
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120-MIN time point for glucose only in the analysis looking at change from fasting using all 
available data at that time point.  While there are slight differences in the results between 
analyses, both demonstrate a similar pattern of change in insulin and glucose across experimental 
sessions.  Insulin and glucose appear to decrease during exercise only in 30-EX.  After 30 
minutes of exercise both insulin and glucose rebound and increase to a value higher than REST 
or 10-EX, remaining elevated throughout 120-MIN. 
Table 5 Change in insulin and glucose from fasting at each time point and by experimental condition 
 Experimental Condition  
(change from fasting) 
 
Variable Time REST 10-EX 30-EX P-value 
Plasma 
Insulin 
(μU/ml) 
FAST 17.0 ± 7.5  
(n=9) 
17.5 ± 9.2 
(n=9) 
20.0 ± 9.5 
(n=9) 
0.340 
 ∆30-MIN 61.3 ± 40.6 
(n=7) 
55.6 ± 30.7 
(n=9) 
53.0 ± 41.0 
(n=8) 
0.690 
∆60-MIN 67.4 ± 36.8
 B 
(n=8) 
38.3 ± 22.0 B 
(n=9) 
6.1 ± 8.4 
(n=8) 
0.002A 
∆90-MIN 40.7 ± 36.8 
(n=9) 
39.6 ± 31.0 
(n=9) 
41.0 ± 42.6 
(n=8) 
0.910 
∆120-MIN* 26.8 ± 32.1 
(n=8) 
22.6 ± 16.0 
(n=8) 
38.4 ± 36.0 
(n=8) 
0.115 
Plasma 
Glucose 
(mg/dl) 
FAST 103.7 ± 14.1 
(n=9) 
102.6 ± 11.5 
(n=9) 
99.7 ± 16.0 
(n=9) 
0.310 
 ∆30-MIN 31.6 ± 18.6 
(n=7) 
18.6 ± 20.0 
(n=9) 
26.5 ± 17.3 
(n=8) 
0.138 
∆60-MIN 24.5 ± 28.0 
(n=8) 
1.2 ± 13.1 
(n=9) 
0.6 ± 15.6 
(n=8) 
0.074 
∆90-MIN 6.89 ± 22.4
 B 
(n=9) 
6.1 ± 18.1 B 
(n=9) 
31.6 ± 21.3 
(n=8) 
0.003A 
∆120-MIN* -2.5 ± 20.5
 B 
(n=8) 
-1.23 ± 7.1 B 
(n=8) 
14.9 ± 17.0 
(n=8) 
0.028 A 
 (Values are presented as mean ± standard deviation) 
A Significant difference among experimental conditions 
B Significantly different compared to the 30-EX condition 
*Variables were not normally distributed.   The main effect for condition was determined made 
using Friedman’s test. Post-hoc comparisons were made using the Wilcoxon signed rank test. 
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4.5 CORRELATIONS BETWEEN ENERGY EXPENDITURE AND PLASMA 
INSULIN AND GLCUOSE AUC 
While all subjects successfully completed the exercise sessions at an intensity between 70-75% 
age-predicted maximal heart rate, energy expenditure was not identical between each subjects as 
each subject walked at a different speed and grade to elicit the target heart rate.  To explore 
whether total energy expenditure was related to differences in plasma insulin or glucose AUC, 
separate correlations were performed between the energy expenditure for each exercise session 
and total insulin and glucose AUC (Table 6).  Additionally, separate correlations were performed 
between energy expenditure for each exercise session, and insulin and glucose AUC above 
FAST (Table 6).  10-EX and 30-EX energy expenditure were not normally distributed, and 
correlations were calculated using Spearman’s rank correlation coefficients (ρ).  Correlations 
were calculated using data from subjects with complete data for the 10-EX (n=8) and 30-EX 
(n=7) exercise sessions.  Energy expenditure was determined using ACSM metabolic equations 
for estimating energy expenditure.28 
Significant negative correlations were detected between 10-EX energy expenditure and 
both total plasma insulin AUC (-0.786; p=0.21) and plasma insulin AUC above FAST  
(-0.762; p=0.28).  Correlations between 10-EX energy expenditure and both glucose AUC and 
glucose AUC above FAST were not statistically significant.  None of the correlations between 
30-EX energy expenditure and plasma insulin or glucose AUC were statistically significant. 
Additionally, partial correlations were performed adjusting for body weight and fitness, 
measured as VO2peak in L/min. (Table 6).  When adjusted for body weight, energy expenditure 
remained significantly correlated with plasma insulin AUC in 10-EX.  After adjusting for fitness, 
however, plasma insulin AUC in 10-EX was no longer significantly correlated with energy 
 69 
expenditure.  There were still no significant correlations between 30-EX energy expenditure and 
plasma insulin or glucose AUC after adjusting for body weight and fitness. 
 
Table 6 Correlations for energy expenditure and insulin and glucose AUC 
 10-EX energy expenditure (n=8) 30-EX energy expenditure (n=7) 
 
Spearman’s 
rank 
correlation 
coefficients (ρ) 
Partial 
Correlation 
controlling for 
body weight 
(kg) 
Partial 
Correlation 
controlling 
VO2peak 
(L/min) 
Spearman’s 
rank 
correlation 
coefficients (ρ) 
Partial 
Correlation 
controlling for 
body weight 
(kg) 
Partial 
Correlation 
controlling 
VO2peak 
(L/min) 
Total Plasma 
Insulin AUC 
-0.786* 
(p=0.021) 
-0.834* 
(p=0.020) 
-0.133 
(p=0.809) 
-0.000 
(p=1.00) 
-0.749 
(p=0.087) 
-0.058 
(p=0.913) 
Plasma 
Insulin AUC 
above FAST 
-0.762* 
(p=0.028) 
-0.874* 
(p=0.010) 
-0.048 
 (p=0.400) 
-0.036 
(p=0.939) 
-0.666 
(p=0.149) 
-0.167 
(p=0.752 
Total Plasma 
Glucose AUC 
0.024 
(p=0.955) 
-0.029 
(p=0.951) 
0.380 
(p=0.809) 
0.464 
(p=0.294) 
0.524 
(p=0.286) 
0.360 
(p=0.483) 
Plasma 
Glucose AUC 
above FAST 
0.048) 
(p=0.911) 
-0.254 
(p=0.582) 
0.174 
(p=0.809) 
0.357 
(p=0.432) 
0.029 
(p=0.956) 
0.392 
(p=0.443) 
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5.0  DISCUSSION 
5.1 SUMMARY OF THE MAIN FINDINGS 
The purpose of this study was to compare the effect of 30 minutes of aerobic exercise, 10 
minutes of aerobic exercise, and a resting sedentary condition on postprandial plasma insulin and 
glucose in a group of obese adults.  In the present study neither plasma insulin AUC nor plasma 
glucose AUC was significantly different between any of the experimental conditions.  However, 
the pattern of change for postprandial insulin and glucose was not consistent across these 
conditions.  At 60-MIN, the total change in plasma insulin from fasting was significantly lower 
in the 30-EX condition compared to the REST and 10-EX condition.  At 90-MIN, the REST and 
10-EX condition attenuated the increase in glucose seen in the 30-EX condition.  Insulin AUC 
was also significantly correlated total energy expenditure.  This relationship remained when 
adjusting for body weight but not for fitness. 
  Therefore, the results of the current study indicate that while 30 or 10 minutes of exercise 
may not significantly reduce plasma insulin or glucose AUC, 30 minutes of exercise appears to 
affect the pattern of change observed for insulin and glucose differently than either 10 minutes of 
exercise or a sedentary period.  In addition, total change in insulin during and after exercise may 
also be related to total energy expenditure.  It is possible that this relationship is influenced by 
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fitness, as individuals with greater fitness levels are able to perform more work and expend more 
energy during a 10-minute exercise session.     
5.2 EFFECT OF EXERCISE ON PLASMA INSULIN AND GLUCOSE 
The present study is the first to examine the effect of aerobic exercise on postprandial changes in 
insulin and glucose in a group of obese, nondiabetic adults. Previous research suggests that 
aerobic exercise significantly reduces postprandial insulin and glucose in diabetic adults.22, 83-84, 
87  For example, Poirier et al. reported that regardless of time since last meal, 60 minutes of 
aerobic exercise significantly reduced postprandial blood glucose immediately following 
exercise.83  Larsen et al. also observed a significant decrease in plasma insulin and glucose AUC 
following 45 minutes of continuous moderate intensity aerobic exercise.22  This same group also 
reported similar changes in insulin and glucose AUC following high intensity exercise consisting 
of several 4-minute intervals at 100% VO2max.84  Similarly, van Dijk et al. reported a dose-
dependent decrease in postprandial insulin and glucose following 30 and 60 minutes of moderate 
intensity aerobic exercise.87 While prior research has observed a decrease in postprandial insulin 
and glucose following exercise, no study has examined this effect in nondiabetics.  Therefore, 
the purpose of the current study was to determine if similar changes in postprandial insulin and 
glucose would be observed in a group of obese, nondiabetic adults following acute exercise.  
Based on prior research, it was hypothesized that an acute bout of both 10- and 30-
minutes of exercise would decrease postprandial insulin and glucose in a dose-dependent manner 
compared to a resting condition.    Results from the current study indicate that plasma insulin and 
glucose AUC were lower following either a 10- or 30-minute bout of exercise compared to a 
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resting condition, but this decrease was not statistically significant.  Therefore, we failed to reject 
the null hypothesis that 10 and 30 minutes of exercise would significantly decrease plasma 
insulin and glucose. 
The results from the present study are in contrast to the majority of prior research which 
observed a significant decrease in postprandial insulin and/or glucose following aerobic exercise.  
However, the observations in the present study agree with one early study by Caron et al. which 
examined postprandial changes in insulin and glucose in a group of type 2 diabetics.  This group 
reported a delay in the postprandial insulin response when subjects performed 45 minutes of 
aerobic exercise at 50% VO2max, but this was delay was not statistically significant.  Similarly, a 
plasma glucose was lower following exercise, but this also failed to reach statistical significance.   
5.2.1 Effect of exercise on plasma insulin AUC 
The present study did not observe a significantly lower plasma insulin AUC in either exercise 
condition compared to a resting session in a group of obese, nondiabetic adults.  These results are 
in contrast to previous research reporting decreases in fasting insulin with acute exercise in obese 
adults.81, 100  In an early study by Minuk et al., 45 minutes of aerobic exercise at 60% VO2max 
significantly decreased plasma insulin during exercise.81  Kang et al. reported similar findings 
and observed a significant decrease in plasma insulin after both 70 minutes of exercise at 50% 
VO2peak and 50 minutes of exercise at 70% VO2peak.100  However, results from the current study 
are in agreement with a study by Giaccia et al. which also did not observe a significant decrease 
in insulin following acute exercise.101   In the trial by Giaccia et al. there was a non-significant 
trend for lower plasma insulin levels following 45 minutes of aerobic exercise at 50% VO2max.  
The present study observed similar results (Figure 3), as total plasma insulin AUC was lower in 
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both 30-EX (11,479±4810) and 10-EX (10,633±5,162) compared to REST (12,270±6,148), but 
these differences did not reach statistical significance (p=0.354). 
The majority of studies examining exercise-induced changes in plasma insulin have been 
performed in the fasting state, while the current study examined postprandial changes.  There is 
one previous study exploring the effect of acute exercise on postprandial insulin in nondiabetic 
subjects.40  In this study by Murphy et al., men and women performed 30 minutes of aerobic 
exercise at 60% VO2max before breakfast, or 10 minutes of aerobic exercise at the same intensity 
before breakfast, lunch and dinner.  Blood was sampled throughout the day, and there was no 
difference in plasma insulin concentrations at any time point between the two conditions.  
Therefore, the current study agrees with the results reported by Murphy et al., suggesting that 
exercise may not change postprandial insulin in obese adults.  However, Murphy et al. included 
both lean and obese subjects in their sample, making it difficult to compare the findings to the 
current study.  Additionally, the sample size of the current study (n=9; n=5 for complete data at 
all time points) and the trial by Murphy et al. (n=7) were both small, further limiting 
interpretation of the results.  It is possible that these studies were underpowered to detect a 
significant difference in insulin between conditions.  However, there is also potentially a 
different mechanism responsible for exercise-induced changes performed in the fasting 
compared to the postprandial state.   
5.2.2 Effect of exercise on AUC for plasma glucose 
A decrease in plasma glucose following exercise is well documented in type 2 diabetic 
subjects.81-82, 100-101 However, changes in glucose may be less common in obese nondiabetics.  
Miunk et al. observed decreased glucose in a diabetic subjects but not obese nondiabetics 
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following 45 minutes of moderate intensity aerobic exercise. 81  Kang et al. also reported a 
significant decrease in plasma glucose in obese diabetics following exercise at both 50% and 
70% of VO2peak, while no change was detected in obese nondiabetics.100  Similarly, Giacca et al. 
reported a significant decrease in glucose in obese diabetics but not obese nondiabetics following 
45 minutes of aerobic exercise at 50% VO2max.101 In the current study, plasma glucose AUC was 
lower in 30-EX (22,899±3,328) and 10-EX (21,735±2,680) compared to REST (23,184± 6,023); 
however, this difference was not statistically significant (p=0.554).  
While the literature suggests that acute exercise may not change fasting plasma glucose 
in obese adults, no studies have examined this population in the postprandial state. Considering 
several studies have reported a significant change in postprandial glucose with exercise in 
diabetics,22, 83-84 the present  investigation examined the effect of exercise on glucose and insulin 
following a breakfast meal.   The exercise sessions in the current study were performed 30 
minutes after consuming a meal containing 20% of estimated energy requirement, and a 
macronutrient distribution of 55% carbohydrate, 30% fat and 15% protein.  This energy and 
macronutrient content is consistent with the meals used in previous studies reporting a significant 
change in glucose and insulin with exercise.22, 84  
The disagreement between results in the present study and previous research may be 
related to differences in fasting glucose levels between subjects.  In the current study mean 
fasting plasma glucose was 102.0±3.2 mg/dl, classifying the population as pre-diabetic.  In 
studies reporting significant changes in postprandial glucose with exercise, mean fasting plasma 
glucose ranged from 144.4±14.4 mg/dl87 to 164.0±9.0 mg/dl.84  It is possible that exercise only 
decreases blood glucose when basal levels are elevated beyond a certain threshold.  Therefore, 
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the fasting plasma glucose may have been too low in the current sample to observe a significant 
change due to exercise. 
5.2.3 Potential influence of methodological differences between studies 
There are methodological differences between the current study and previous research that may 
provide insight on the differences in findings. 
5.2.3.1 Volume of exercise  
The current study utilized 10- and 30- minute bouts of acute aerobic exercise at 70-75% age-
predicted maximal heart.  Thirty minutes was chosen for the longer exercise session as it reflects 
current guidelines for exercise in healthy adults.26, 28 These guidelines also suggest that exercise 
may be accumulated in minimum 10-minute bouts,26-28 thus 10-minutes was chosen as the 
duration of the shorter exercise session.  While 10- and 30-minute bouts of aerobic exercise 
agree with current exercise recommendations for health, most prior literature reporting a 
significant decrease in postprandial insulin and glucose utilized exercise sessions of greater 
duration and/or intensity than the current study.  Poirier et al. observed significant decreases in 
blood glucose following 60 minutes of exercise at 60% VO2peak.83  Studies by Larsen et al. 
reported lower insulin and glucose following 45 minutes of bicycling at 45% VO2max,22 and 
intermittent high intensity exercise performed as four, 4-minute high intensity intervals at 100% 
of VO2max.84  Significant decreases in glucose were also observed by van Dijk et al. following 
either 30- or 60-minutes of bicycling at 50% of maximal workload.87  Therefore, 10- or 30-
minute bouts of acute moderate intensity exercise may not have been of sufficient duration or 
total volume to detect a significant decrease in insulin or glucose. 
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5.2.3.2 Total energy expenditure and muscle glycogen utilization 
Insulin secretion is thought to be dependent on total energy availability, indicating that exercise 
of insufficient volume or total energy expenditure may not decrease insulin and subsequently 
lower glucose.  Larsen et al.22 have reported results supporting this theory.  They observed 
similar decreases in postprandial insulin following 45 minutes of bicycling at 45% VO2max and 
after consuming a breakfast that was reduced the number of calories equivalent to expenditure 
during the exercise session.  Results from the current study also observed a relationship between 
energy expenditure and plasma insulin, with a significant correlation between greater energy 
expenditure during the 10-EX session and lower insulin AUC observed.  Additionally, it is 
thought that muscle glycogen depletion is related to decreases in insulin.  Increases in insulin 
sensitivity have been correlated to muscle glycogen utilization.100, 102  Therefore, there may be 
thresholds for total energy expenditure and glycogen utilization that must occur to significantly 
reduce plasma insulin or glucose.  It is possible that 10 or 30 minutes at 70-75% age-predicted 
maximal heart rate is below this threshold, which may have influenced plasma insulin or glucose 
response in this study.  
5.2.3.3 Differences in participant characteristics 
The present study was the first to examine the effect of acute aerobic exercise on postprandial 
changes in insulin and glucose in nondiabetic obese subjects.  The four studies which previously 
observed a significant decrease in postprandial insulin and glucose were performed in type 2 
diabetics either treated with diet,22, 84 oral hypoglycemic agents,83, 87 or  insulin therapy.87  Adults 
with overt type 2 diabetes are likely more hyperglycemic, hyperinsulinemic and insulin resistant 
than the pre-diabetic population in the current study.  It is possible that hyperglycemia and 
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hyperinsulinemia must be more severe than what was observed in the population currently 
studied to produce significant exercise-induced changes in insulin and glucose. 
5.2.3.4 Timing of blood collection 
The current study collected a blood sample in the fasted state and then fed subjects a breakfast 
meal.  Subjects were observed for 120-minutes following breakfast consumption and blood was 
collected at 30 minute intervals (Figure 1).  The three previous studies utilizing a similar study 
design sampled blood more frequently than every 30 minutes,22, 84, 87 and all observed a 
significant decrease in insulin and glucose when exercise was performed in the postprandial 
state.  Therefore, it is possible that blood was not sampled frequently enough and failed to 
capture a time point during which significant changes in insulin or glucose were occurring. 
5.3 DIFFERENCES IN THE PATTERN OF CHANGE FOR INSULIN AND 
GLUCOSE 
5.3.1 Pattern of change in plasma insulin across experimental conditions 
 Insulin AUC was not statistically different between REST, 10-EX and 30-EX in the current 
study.  However, the pattern of change between time points was not consistent across the three 
experiment conditions (Figure 7, Table 4).  Insulin increased following the breakfast meal to 30-
MIN in all treatment conditions, which was the expected response to the meal.  Exercise was 
initiated at 30-MIN in 10-EX and 30-EX, while subjects remained sedentary in the REST 
condition.  Following exercise, insulin was reduced at 60-MIN in both 10-EX and 30-EX 
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compared to REST, with a larger decrease observed in 30-EX.  There was a significant main 
effect between conditions (p=0.018) at 60-MIN, but no significant differences were detected with 
post-hoc comparisons using a Bonferonni adjustment.  From 60-MIN to 90-MIN, plasma insulin 
decreased in REST and stayed relatively stable in 10-EX.  In 30-EX, insulin rebounded to a level 
that was higher, but not statistically different, compared to REST or 10-EX at 90-MIN.  Plasma 
insulin decreased from 90-MIN to 120-MIN in all three groups, and plasma insulin was 
significantly higher in 30-EX than REST at 120-MIN (p=0.042).  
In the current study, this pattern of change for insulin was consistent across the majority 
of subjects (Appendix N).  seven total subjects had complete data for the 30-EX condition, and 
six of these subjects demonstrated a decrease in insulin during exercise and a subsequent 
rebound post-exercise. Other studies have reported a similar pattern for insulin following acute 
aerobic exercise. This “insulin rebound” has been observed under fasting conditions in lean86 and 
obese subjects,81, 86 and during the postprandial period in diabetics.22, 84 
 One potential contributor to this “insulin rebound” is increased sympathetic nervous 
system activity during exercise.  In the study by Larsen et al., plasma catecholamine responses 
were also measured throughout 45 minutes of exercise and the post-exercise period.  They 
reported that changes in insulin occurred inversely to changes in plasma epinephrine and 
norepinepherine.84 The authors concluded that increased sympathetic nervous system activity 
might depress β-cell secretion of insulin during exercise.  Then, catecholamine concentrations 
decrease at the cessation of exercise and insulin secretion is no longer suppressed, resulting in a 
rebound in insulin secretion.   
 While previous research consistently reports a rebound in plasma insulin following 
aerobic exercise, the exercise sessions utilized in these studies were all a minimum of 30 minutes 
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in duration.22, 81, 84, 86 The current study is the first to examine a shorter exercise session, 
specifically an acute 10-minute bout.  In the present study, insulin was reduced during and 
immediately post-exercise in 10-EX compared to REST, although this difference was not 
statistically significant.  However, the “insulin rebound” observed in 30-EX did not occur in 10-
EX.  Again, this pattern was consistent across the individual responses for the majority of 
subjects (Appendix N).  Complete data was collected on all but one subject for the 10-EX 
condition, who was only missing the 120-MIN blood draw.  A rebound effect for insulin in 10-
EX was only observed in one subject.  In the other eight subjects, plasma insulin in 10-EX either 
continued to decrease or remained stable following exercise. This consistent observation among 
subjects suggests that the effect of 30-minutes of exercise appears to be different than the effect 
of 10-minutes on the pattern of change for insulin during and after exercise.   
 The differences in pattern of change for insulin between a 10- and 30-minute bout of 
exercise is interesting, particularly the absence of the post-exercise rebound following 10 
minutes of exercise.  Both exercise sessions were performed at the same intensity; subjects 
averaged 72±3.5% and 73±1.8% of age-predicted maximal heart rate during exercise in 10-EX 
and 30-EX, respectively.  Therefore, there appears to be a physiological response occurring 
sometime after 10-minutes of moderate intensity exercise that is responsible for the post-exercise 
rebound in insulin.  Since studies have speculated that catecholamine concentrations might 
contribute to the insulin rebound,22, 84 it is possible that 10-minutes of exercise does not elicit a 
strong enough catecholamine response to result in the “insulin rebound.”  However, the purpose 
of this study was not to determine the physiological mechanisms responsible for changes in 
insulin with exercise.  Additional studies are necessary to determine why the “insulin rebound” 
was not observed following 10 minutes of exercise in the present investigation.  
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5.3.2 Pattern of change in plasma glucose across experimental conditions 
The pattern of change in plasma glucose across the experimental conditions in the current study 
followed a similar pattern as plasma insulin (Figure 8, Table 4).  Glucose increased from FAST 
to 30-MIN, demonstrating an increase in blood glucose from the meal.  Plasma glucose then 
decreased from 30-MIN to 60-MIN in all conditions.  Following exercise, mean plasma glucose 
was lower in 10-EX and 30-EX compared to REST at 60-MIN, but these differences were not 
statistically significant.  From 60-MIN to 90-MIN, glucose continued to decrease in REST and 
stayed relatively stable in 10-EX.    In 30-EX, plasma glucose rebounded to a much higher level 
at 90-MIN.  This rebound is similar to the pattern observed for plasma insulin in 30-EX at the 
same time point.  A significant main effect for condition (p=0.037) was detected at 90-MIN, with 
higher mean plasma glucose in 30-EX (147.6±29.0) compared to 10-EX (122.2±21.5) or REST 
(121.4±38.0).  However, post-hoc analysis did not reveal any statistically significant differences 
between time points.  From 90-MIN to 120-MIN glucose decreased in all three conditions.  
Glucose was higher at 120-MIN in 30-EX compared to 10-EX or REST, although no statistical 
differences were detected at this time point.  This pattern was to similar observations for insulin 
at the same time points in the present study.  
Similar to insulin, the rebound effect observed for glucose in 30-EX was consistent 
across the majority of subjects in the present study (Appendix O).  Complete data was available 
for 7 subjects for 30-EX, and five of these demonstrated a rebound response for plasma glucose 
following exercise.  Eight subjects had data at all time points for the 10-EX session.  In 
comparison to 30-EX, the pattern for glucose changes was slightly more varied in 10-EX.  Upon 
visual inspection, blood glucose appeared to slightly decrease or stay relatively stable following 
exercise at 90-MIN in five subjects.  A slight rebound effect was observed for plasma glucose in 
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three of the subjects at 90-MIN, but glucose was never higher in 10-EX compared to 30-EX at 
any point following exercise in any of the subjects. While statistically significant differences 
were only detected at 60-MIN for glucose, the consistency in the post-exercise rebound in 
glucose observed among individual subjects suggests that 30-minutes affects plasma glucose 
changes differently than 10-minutes of aerobic exercise.  Therefore, the individual responses also 
indicate that a stronger rebound effect is observed following 30 minutes of exercise compared to 
a 10-minute bout.   
5.3.3 Clinical implications of findings 
The current study is the first to compare the acute effect a single 10-minute exercise session, a 
single 30-minute exercise session, and a resting condition on postprandial plasma insulin and 
glucose in an obese population.  Physical activity recommendations suggest aerobic activity can 
be accumulated in multiple short bouts lasting at least 10 minutes.26-28 Current research supports 
the effectiveness of accumulating short bouts of aerobic exercise to improve cardiovascular 
fitness29-36 and promote weight loss. 29-31  However, there are few published studies examining 
the effectiveness of multiple short bouts of exercise on other health outcomes, including insulin 
and glucose.   
The results from the present study suggest that accumulating aerobic activity in multiple 
10-minute bouts may be equally or more effective as performing a single 30-minute session to 
decrease insulin and glucose.  The current study observed that insulin and glucose AUC were not 
statistically different in 10-EX or 30-EX.  These results suggest that 30 minutes of exercise is not 
superior to 10 minutes for decreasing total circulating levels of plasma glucose during and 
immediately after exercise.  However, post-exercise plasma insulin was significantly higher at 
 82 
120-MIN in 30-EX compared to REST (Figure 7).  Therefore, it is possible that performing 
multiple 10-minute bouts of exercise would prevent the post-exercise rebound in insulin that 
observed following a single 30-minute bout of exercise.    
This study was limited to the effect of a single exercise session.  Few studies have 
reported the chronic effect of performing short bouts of exercise compared to a single, longer 
bout on changes in insulin and glucose.  Donnelly et al. had overweight women accumulate short 
bouts of activity (two 15-minute sessions per day, five days per week at 50-65% VO2max) or 
perform a single exercise session (three, 30-minute sessions three times per week at 60-75% 
VO2max) for 18 months.32  At the end of the training period, both groups demonstrated lower 
insulin AUC during an OGTT, but fasting insulin only decreased in the accumulated exercise 
group. There was no significant decrease in any measures of glucose in either group.   
Eriksen et al. performed a similar study in a group of overweight or obese type 2 diabetic 
males.37  Subjects completed a single 30-minute exercise session or three, 10-minute exercise 
sessions per day for 5 weeks. Improvements in fasting glucose and glucose response to an OGTT 
were only observed in the group performing multiple 10-minute sessions. However, no changes 
in fasting insulin or insulin response to an OGTT were reported in either group.  These two 
studies indicate that accumulating multiple short bouts of exercise is as effective for managing 
glycemic control as one longer bout, and may confer some additional benefit.  
The current study was not designed to examine the chronic effect of multiple10-minute 
bouts compared to a single 30-minute bout of exercise on changes in insulin and glucose.  
However, the present study observed elevated insulin following 30-minutes of exercise, and 
Donnelly et al. observed a decrease in fasting insulin only in subjects performing multiple short 
bouts of exercise. 32   Similarly, the results from Erikesen et al. suggest that in diabetics, short 
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bouts of exercise may more effectively manage hyperglycemia than a single longer bout.37 It is 
therefore possible to hypothesize that accumulating short bouts of exercise may be more 
effective for managing insulin and glucose compared to a single, longer exercise bout.   
5.4 LIMITATIONS AND RECOMMENDATIONS FOR FUTURE RESEARCH 
This study was designed to examine the effect of 10 and 30 minutes of acute aerobic exercise on 
plasma insulin and glucose in a group of obese adults.  However, there are factors that may have 
impacted results, and the outcomes should be interpreted accordingly.  These limitations are 
described in the following section.  Additionally, recommendations for future research are 
discussed below:  
1. This study was limited to obese (BMI 30.0-<45.0 kg/m2), sedentary, apparently healthy 
men and women between the ages of 35 and 55.  Therefore, caution should be used when 
generalizing these findings to other populations, such as normal weight adults or 
diabetics.  Type 2 diabetics are likely to be characterized by more severe hyperglycemia 
and hyperinsulinemia compared to the population in the current study.  It is unknown if 
10- and 30-minute bouts would have the same effect on insulin and glucose in diabetics; 
future studies should examine the effect of 30 minutes versus 10 minutes of exercise on 
insulin and glucose in subjects with type 2 diabetes. 
2. This study was underpowered to detect significant differences in postprandial plasma 
insulin and glucose between a resting condition, 10-minute exercise condition and a 30-
minute exercise condition.  It was determined a priori that 25 subjects were necessary to 
detect a significant difference in plasma insulin and glucose.  However, 11 subjects were 
 84 
recruited for this study, 9 completed all three experimental sessions, and blood was 
obtained at all time points in only 5 subjects.  Therefore, the primary analyses were 
conducted using data from these 5 subjects.  Even with the small sample size a significant 
main effect for condition was detected at 60-MIN and 120-MIN for plasma insulin, and at 
90-MIN for glucose (Table 4). In addition, post-hoc analyses reported that plasma insulin 
was significantly higher in 30-EX compared to REST at 120-MIN, while REST and 10-
EX were not significantly different from each other.  Additionally, similar patterns in 
changes for insulin and glucose were observed among the majority of subjects when 
individual data was reviewed (Appendix N and O).   These results suggest that 
differences may exist in the plasma insulin and glucose response to a 10- and 30-minute 
bout of exercise.  Appropriately powered studies should be conducted in the future to 
further explore this question. 
3. The exercise sessions examined in this study included a 10- and 30-minute bout of 
treadmill walking at 70-75% age-predicted maximal heart rate.  It is possible that this 
volume of exercise was not enough to elicit a response in plasma insulin and glucose.  
Other studies reporting significant changes in postprandial plasma insulin and glucose 
have utilized exercise sessions that were a longer duration and/or a higher intensity than 
the protocol in the current study.22, 84, 87  Therefore, future studies should consider using a 
greater volume of exercise when studying changes in insulin and glucose in obese, 
nondiabetic adults. 
4. Blood draws were obtained using a needle stick at five time points over the course of the 
testing sessions.  For some subjects, multiple attempts were necessary in order to obtain a 
sample, which delayed the time at which that particular blood draw occurred.  
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Considering the sensitivity of the time points for changes in insulin and glucose, it is 
possible that any delays in obtaining blood samples may have impacted the results.  
Obtaining blood at 60-MIN in the 30-EX condition was particularly difficult since the 
blood draw occurred immediately upon cessation of exercise.  Additionally, blood draws 
were not completed at all time points for some subjects, resulting in only 5 subjects 
having complete data. Using an angiocatheter may be a more suitable method for drawing 
blood for this research design and should be considered in future research. 
5. Blood was obtained in the fasting state and then every 30-minutes following a breakfast 
meal over a 120-minute time period, for a total of five blood draws during each 
experimental session.  Previous research reporting significant changes in postprandial 
insulin and glucose sampled blood more frequently than every 30 minutes.22, 84, 87 It is 
possible that blood should be sampled on a more frequent basis to more accurately 
determine changes in plasma insulin and glucose.  Because this study was unable to use 
an angiocatheter and required five separate needle sticks it was not feasible to sample at 
more frequent intervals, primarily due to subject burden.  Therefore, future studies may 
consider using an angiocatheter to obtain blood and draw these samples more frequently 
than 30-minute intervals in order to increase the likelihood of detecting significant 
changes in plasma insulin and glucose.  
6. This study only explored differences in plasma insulin and glucose with 10-minutes of 
exercise compared to 30-minutes of exercise.  It would be interesting to also assess if 
there are any differences in affect or subject attitude towards different durations of 
exercise in future studies.  While subjects were not formally surveyed on their feelings or 
attitudes toward the exercise sessions, several expressed that completing the 30-minute 
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session was very difficult.  These opinions were not expressed as strongly during the 10-
minute bout.  Although this was an informal observation made by the investigator, it also 
warrants additional investigation as it may impact the likelihood that individuals would 
actually perform recommended exercise sessions. 
7. This study only examined the acute effect of 10- and 30-minutes of exercise compared to 
a resting condition.  It is unknown how chronic exercise training performed in multiple 
10-minute bouts compared to a single 30-minute bout may affect insulin and glucose in 
obese, non-diabetic adults.  Differences in insulin and glucose between these sessions 
will only contribute to better health outcomes if changes are observed following chronic 
exercise training.  Therefore, future studies should examine the long term effect of 
performing multiple 10-minute bouts compared to a single 30-minute bout. 
8. The current study was not designed to investigate any difference in physiological 
mechanisms responsible for changes in plasma insulin and glucose between a 10 and 30-
minute bout of exercise.  This study demonstrated that the pattern of change for both 
insulin and glucose was different following 10 minutes of exercise compared to 30 
minutes of exercise.  Therefore, future research should focus on examining the 
mechanisms responsible for the rebound in insulin and glucose following 30 minutes of 
exercise that was not observed after the 10 minute session.  It is also necessary to 
determine if this rebound effect following exercise is beneficial or detrimental to any 
health outcomes, as this would affect how exercise should be prescribed to an obese, non-
diabetic population. 
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5.5 CONCLUSIONS 
Obesity is associated with insulin resistance, and accompanying hyperinsulinemia and 
potentially hyperglycemia.  Acute exercise is associated with a decrease in postprandial insulin 
and glucose in type 2 diabetics, but it is unknown if this same effect occurs in obese, nondiabetic 
adults.  Additionally, physical activity recommendations suggest that aerobic exercise may be 
accumulated in multiple 10-minute bouts throughout the day. It is currently unknown if 10 
minutes of exercise sufficiently decreases insulin and glucose compared to a single 30-minute 
bout.  Therefore, the current study examined the effect of 10 and 30 minutes of acute exercise on 
postprandial insulin and glucose in obese, nondiabetic adults. 
Results from the current study suggest that there is no statistically significant difference 
in plasma insulin and glucose AUC between 10 and 30 minutes of exercise and a sedentary 
condition during a 120-minute postprandial period.  However, when each time point was 
analyzed individually, the pattern of change observed for plasma insulin and glucose was not 
consistent across conditions.  Specifically, 30-minutes of exercise decreased plasma insulin and 
glucose during exercise, with a subsequent increase immediately post-exercise.  This rebound in 
insulin and glucose was not observed in either the 10-minute exercise session or sedentary 
condition.  Therefore, it appears that both 10 and 30 minutes of exercise effectively decrease 
plasma insulin and glucose.  Additionally, it is possible that 10 minutes of exercise may be more 
beneficial than 30 minutes if there are any negative health outcomes associated with the post-
exercise rebound in insulin and glucose.  Additional studies are necessary to clarify these 
findings and determine the chronic effect of performing either a single 30-minute session 
compared to multiple 10-minute sessions on a daily basis.   
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In conclusion, while the initial hypothesis that 10- and 30-minutes of aerobic exercise 
would decrease plasma insulin and glucose AUC was not accepted, additional analyses revealed 
interesting differences in the pattern of change between the treatment conditions.  Specifically, 
there was a significant main effect for treatment condition at 60-MIN and 120-MIN for insulin, 
and insulin was significantly greater in 30-EX compared to REST at 120-MIN.  For glucose, a 
significant main effect was detected at 90-MIN.  These results suggest that postprandial insulin 
and glucose decrease to a greater degree during 30-minutes of exercise compared to 10-minutes 
of exercise or a resting condition, with a subsequent “rebound” observed post-exercise.  
Additionally, this pattern was consistent among subjects, with insulin and glucose following this 
pattern in the majority of subjects when observing each subject individually.  
Therefore, results from the current study suggest that the differences in pattern of change 
following 10- and 30-minutes of exercise warrants further investigation.  It is possible that this 
study was underpowered to detect significant differences in plasma insulin and glucose AUC.  
However, the significant differences in pattern of change between 10- and 30-minutes of exercise 
observed in this study suggest that the insulin and glucose “rebound” may be the mechanism 
responsible for lower insulin and glucose following chronic exercise performed in short bouts.   
As this study was not designed to evaluate the chronic effect of multiple 10-minute versus a 
single 30-minute bout of exercise, this is an area of research that should be examined in the 
future as the difference in the pattern of insulin response to 10- and 30-minutes of exercise may 
have clinical implications for individuals with hyperinsulinemia and insulin resistance.   
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APPENDIX B 
PHYSICIAN CONSENT 
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PHYSICIAN CONSENT TO PARTICIPATE IN A DIET AND EXERCISE PROGRAM AT THE  
UNIVERSITY OF PITTSBURGH 
 
TO:  RETURN TO: (envelope provided) 
 Physician’s Name Anne Mishler, M.S. 
  University of Pittsburgh 
  Department of Health and Physical Activity 
 Address Physical Activity and Weight Management Research Center 
   2100 Wharton Street, Suite 600 
  Pittsburgh, PA  15203 
 City State Zip Telephone:  (412) 488-4184 
  FAX: (412) 488-4174 
 (          )  
 Telephone Number  
 
Your patient ______________________________ has asked to participate in an exercise study at the 
University of Pittsburgh.  This is study is examining the effect of different durations of exercise (10 minutes 
compared to 30 minutes).  Subjects cannot be diagnosed with Type I or Type II diabetes.  This study will 
involve the following. 
1. A graded exercise test which involves walking on a motorized treadmill, with the workload gradually 
increasing every minute.  The test will be terminated when the patient achieves 85% of their age-
predicted maximal heart rate, or prior to this level if the individual experiences signs or symptoms that 
would indicate that exercise is contraindicated.  Both blood pressure and heart rate will be monitored 
continuously.  The ACSM Guidelines for Exercise Testing will be followed. 
2. Two exercise testing conditions at 70% to 75% of age-predicted maximal heart rate.  One exercise 
session will be 10 minutes in duration, and the other will be 30 minutes in duration. 
3. A list of additional factors that are exclusionary criteria for this study that you should consider are listed 
on the attached sheet.  
******************************************************************************************** 
Please indicate below if this program seems appropriate for your patient or if you see any 
contraindications for her participation (please check the appropriate box below).   
 I verify that this patient has not been diagnosed with Type I or Type II Diabetes and know of no 
contraindications to this patient participating in any of the above components of the program. 
 I feel that this program would not be appropriate for this patient for the following reason(s): 
 
 
   
Signature of Physician  Date 
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Please consider the following Inclusion and Exclusion Criteria as you evaluate whether your 
patient is capable of safely participating in the weight loss and exercise research study at the 
University of Pittsburgh. 
 
 
Inclusion Criteria: Exclusion Criteria: 
• Female or Male • Previous diagnosis of cancer, heart disease, Type 
I or Type II diabetes, or polycystic ovarian 
syndrome.   
• 35-55 years of age 
• BMI = 30.0-<45.0kg/m2 
• Sedentary for the past 6 months 
(performing less than 60 minutes of 
exercise per week over the past 6 
months) 
• Taking prescription or over-the-counter 
medications that affects glucose metabolism, 
insulin, blood pressure or heart rate.   
• Ability to provide consent from their 
personal physician to participate in 
this study. 
• Presence of any condition that may limit one’s 
ability to walk for exercise (e.g., orthopedic 
limitations or severe arthritis).   
•  • Currently participating in a weight loss program 
or reporting significant weight loss (>3.0% of 
body weight) in the past month.   
•  • Women who are currently pregnant (all females 
will have a urine pregnancy test prior to 
participating in all experimental sessions) 
•  • Having a resting systolic blood pressure of ≥140 
mmHg or a diastolic blood pressure of ≥90 
mmHg or currently taking prescription 
medication to control blood pressure.     
•  • Premenopausal women reporting irregular 
menstrual cycles (<25 days or >35 days between 
cycles).   
•  • Report consuming more than a moderate amount 
of alcohol (>7 drinks per week for females and 
>14 drinks per week for males) 
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ASSESSMENT INSTRUCTIONS 
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Dear Participant, 
 
Thank you again for participating in the Exercise Study. At this point, you have 
completed the orientation session and initial screening questions. You will now need to 
come back to the laboratory for an assessment visit.  Your assessment visit is 
scheduled for:  
 
___________________________ 
 
If at any point you realize that you need to reschedule, please call our office 
immediately at 412-488-4170. Assessment times are limited at our center, thus, it is 
extremely important that you make a strong effort to attend when scheduled. 
If at any point you realize that you need to reschedule, please call our office 
immediately at 412-488-4170.   
 
Prior to your visit, we ask that you adhere to the following guidelines: 
1. Abstain from caffeine for at least 4 hours. 
2. Fast for at least 4 hours (no food or drink other than water). 
3. Avoid consumption of over-the-counter medications for 24 hours. 
4. Refrain for vigorous physical activity for 24 hours. 
5. Transport yourself to the Physical Activity and Weight Management Research 
Center in a method that does not allow for excessive physical exertion (i.e., car 
or bus). 
Be sure to report to our center with clothing and shoes that are comfortable for 
exercising.  Please make sure you wear closed toed shoes. You may wear these 
clothes to the center, or you can use our changing facilities when you get here. If you 
have any questions about any of these guidelines, please feel free to contact Annie 
Mishler at 412-488-4170. We look forward to seeing you at your scheduled visits! 
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ASSESSMENT COMPLIANCE QUESTIONNAIRE 
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Exercise Study 
Assessment Compliance Questionnaire 
 
Subject ID: ____________                                                    Date _____________ 
 
 
Please ask the subject the following questions: 
 
 
 Have you fasted for at least 4 hours?   Yes  No 
 
 
 Have you avoided consumption of over-the-counter  
      medications for 24 hours prior to the visit?   Yes  No 
 
 
 Have you abstained from all vigorous physical  
      activity for 24 hours prior to the visit?    Yes  No 
 
 
 Did you transport yourself to the lab in a 
      vehicle?           Yes  No 
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APPENDIX E 
ASSESSMENT DATA COLLECTION FORM 
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“Exercise and Insulin” 
Assessment Form 
 
 
Subject Number:  Acrostic:  
  
  
 
 
 
 
 
 
The assessments must be completed in the following order by the individuals listed.  Under no 
circumstances is this protocol to be altered unless approved by John/Annie for this participant. 
 
***Mark each item as it is completed. 
 
 Greet participant Initial: _____ 
   
 Blood Pressure/Heart Rate Initial: _____ 
   
 Height, Weight, Waist Circumference Initial: _____ 
   
 Exercise test prep Initial: _____ 
   
 Exercise test Initial: _____ 
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“Exercise and Insulin” 
Assessment Form 
 
Subject Number:  _____________________________  Date: ___/___/___ 
 
Acrostic:   _____________________________ 
 
Assessment Period: ___Baseline   
       
 
 
Height:  __________ cm (measure to the nearest 0.1 cm) 
Weight:  __________ kg (read from digital scale to the nearest 0.1 kg) 
BMI:  __________ kg/m2 
Blood Pressure and Heart Rate 
Are you taking blood pressure medication?  ___Yes  ___No 
Time: _________   ___am   ___pm 
Arm Circumference: ________cm   Cuff Size: 
       ___Regular  (24.0 - 32.9 cm) 
       ___Large (33.0 - 41.0 cm) 
       ___Thigh (> 41.0 cm) 
 *Systolic Pressure **Diastolic Pressure 
First Reading   
   
Second Reading   
   
***Third Reading   
   
*The two Systolic Pressures should differ by > 10 mmHg 
**The two Diastolic Pressures should differ by > 6 mmHg 
*** If above criteria are not met take additional readings until these criteria are met. 
 
 Heart rate (read from Dinamap) 
First Reading  
  
Second Reading  
  
***Third Reading  
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 “Exercise and Insulin” 
Assessment Form 
 
 
Subject Number: _____________________________  Date: ___/___/___ 
 
Acrostic:   _____________________________ 
 
Assessment Period: ___Baseline   
    
 
 
Additional Information for GXT: 
 
Age:_____ years 
 
Date of birth: ___/___/_____ (month/day/year) 
 
 
 
 
Girths  
(Measured in centimeters to 1 decimal point) 
 1st  
Measurement 
2nd 
Measurement 
*3rd 
Measurement 
Waist 
(taken at the level of the iliac 
crest) 
   
*Take a third measurement only if the difference between the first and second measurement is > 1.0cm. 
 
 
 
 
 
Urine Pregnancy Test Completed (females only):  ____ Yes ____ No 
 
If “No” explain why: __________________________________________ 
 
Results of Urine Pregnancy Test: ____Positive (do not proceed) 
       ____Negative 
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Graded Exercise Test 
ID#:_________________ Date: _________________ 
Age: ________ years             Height: _________ cm Weight: _________ lbs 
Termination Heart Rate: _______ bpm (85% of Age-Predicted Max Heart Rate) 
Time (minutes) Speed (mph) %Grade Heart Rate (bpm) Blood Pressure RPE 
0:00-1:00 3.0 0.0%  XXXXX XXXXX 
1:01-2:00 3.0 1.0%  /  
2:01-3:00 3.0 2.0%  XXXXX XXXXX 
3:01-4:00 3.0 3.0%  /  
4:01-5:00 3.0 4.0%  XXXXX XXXXX 
5:01-6:00 3.0 5.0%  /  
6:01-7:00 3.0 6.0%  XXXXX XXXXX 
7:01-8:00 3.0 7.0%  /  
8:01-9:00 3.0 8.0%  XXXXX XXXXX 
9:01-10:00 3.0 9.0%  /  
10:00-11:00 3.0 10.0%  XXXXX XXXXX 
11:01-12:00 3.0 11.0%  /  
12:01-13:00 3.0 12.0%  XXXXX XXXXX 
13:01-14:00 3.0 13.0%  /  
14:01-15:00 3.0 14.0%  XXXXX XXXXX 
15:01-16:00 3.0 15.0%  /  
16:01-17:00 3.0 16.0%  XXXXX XXXXX 
17:01-18:00 3.0 17.0%  /  
18:01-19:00 3.0 18.0%  XXXXX XXXXX 
19:01-20:00 3.0 19.0%  /  
20:01-21:00 3.0 20.0%  XXXXX XXXXX 
21:01-22:00 3.0 21.0%  /  
22:01-23:00 3.0 22.0%  XXXXX XXXXX 
23:01-24:00 3.2 22.0%  /  
24:01-25:00 3.4 22.0%  XXXXX XXXXX 
25:01-26:00 3.6 22.0%  /  
26:01-27:00 3.8 22.0%  XXXXX XXXXX 
27:01-28:00 4.0 22.0%  /  
28:01-29:00 4.2 22.0%  XXXXX XXXXX 
29:01-30:00 4.4 22.0%  /  
Termination 
Time: ___:___ 
   /  
Recovery: 
0:00-1:00 2.5 0.0%  XXXXX XXXXX 
1:01-2:00 2.0 0.0%  / XXXXX 
2:01-3:00 1.5 0.0%  XXXXX XXXXX 
3:01-4:00 Seated Seated  / XXXXX 
4:01-5:00 Seated Seated  XXXXX XXXXX 
5:01-6:00 Seated Seated  / XXXXX 
6:01-7:00 Seated Seated  XXXXX XXXXX 
Reasons the Test was Terminated: 
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TESTING SESSION INSTRUCTIONS 
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Dear Participant, 
 
Thank you again for participating in the Exercise Study. At this point, you have 
completed the initial assessment visits and now have three, 3-hour testing sessions that 
must be performed prior to completion of this study. Your 3 testing sessions have been 
scheduled for: 
1. ___________________________________________ 
 
2. ___________________________________________ 
 
3. ___________________________________________ 
 
If at any point you realize that you need to reschedule, please call our office 
immediately at 412-488-4170.   
 
Prior to your visit, we ask that you adhere to the following guidelines: 
6. Refrain from exercise for 72 hours prior to the experimental session. 
7. Keep a detailed food record for one day prior to the experimental session. 
8. Avoid alcohol for 24 hours prior to the experimental session. 
9. Abstain from all food and drink other than water for 12 hours prior to the 
experimental session.  This includes abstaining from all caffeinated beverages as 
well as chewing gum and mints. 
Be sure to report to our center with clothing and shoes that are comfortable for 
exercising.  Please make sure you wear closed toed shoes. You may wear these 
clothes to the center, or you can use our changing facilities when you get here. If you 
have any questions about any of these guidelines, please feel free to contact Annie 
Mishler at 412-488-4170. We look forward to seeing you at your scheduled visits! 
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APPENDIX G 
EXPERIMENTAL SESSION COMPLIANCE QUESTIONNAIRE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 118 
Experimental Session Compliance Questionnaire 
 
Subject ID:_______________________ 
 
Date:_____________________________ 
 
 
Session (circle):  REST    10-EX     30-EX 
 
Please ask the subject the following questions: 
 
Have you exercised in the past 2 days? 
 
 
 YES              NO 
 
 
Have you consumed anything other than water 
in the past 12 hours? 
 
 
 YES              NO 
 
 
Did you consume alcohol in the past 24 
hours? 
 
 
 YES              NO 
 
Did you transport yourself to the lab in a 
vehicle? 
 
 
 YES              NO 
 
Did you keep your food record yesterday? 
 
 
 YES              NO 
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APPENDIX H 
RESTING SESSION DATA COLLECTION FORM 
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APPENDIX I 
10-EX SESSION DATA COLLECTION FORM 
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APPENDIX J 
10-EX SESSION TREADMILL DATA COLLECTION FORM 
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10-minute Exercise Session (EX-10) Data Sheet 
 
Subject ID: ______________    Visit #:  _________     Date: __________  
 
Predicted HRmax: ___________ Target HR range (70-75% max HR): ____________    
 
Starting TM grade: __________   Starting TM speed: 3.0 mph  
 
Time % Grade HR 
 
Grade Adjusted (Y/N) 
BL (30 min Rest)    
0 -1 min    
1 - 2 min    
2 - 3 min    
3 - 4 min    
4 - 5 min    
5 - 6 min    
6 - 7 min    
7 - 8 min    
8 - 9 min    
9 - 10 min    
 
 
The treadmill grade/speed will be adjusted using the following protocol: 
 
1) If the heart rate is below the range of 70% to 75% of age-predicted maximal heart rate 
for two consecutive minutes increase the grade by 1.0%  
 
2) If the heart rate is above the range of 70% to 75% of age-predicted maximal heart rate 
for two consecutive minutes decrease the grade by 1%.   
 
3) If a grade of 0% elicits a heart rate above the range of 70% to 75% of age-predicted 
maximal heart rate for two consecutive minutes decrease the speed by 0.2 mph. 
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APPENDIX K 
30-EX SESSION DATA COLLECTION FORM 
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APPENDIX L 
30-EX SESSION TREADMILL DATA COLLECTION FORM 
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30-minute Exercise Session (EX-30) Data Sheet 
 
Subject ID: ______________    Visit #:  _________     Date: __________  
 
Predicted HRmax: ___________ Target HR range (70-75% max HR): ____________    
 
Starting TM grade: __________   Starting TM speed: 3.0 mph  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time % Grade HR 
 
Grade Adjusted (Y/N) 
BL (30 min Rest)    
0 -1 min    
1 - 2 min    
2 - 3 min    
3 - 4 min    
4 - 5 min    
5 - 6 min    
6 - 7 min    
7 - 8 min    
8 - 9 min    
9 - 10 min    
10 - 11 min    
11 - 12 min    
12 - 13 min    
13 - 14 min    
14 - 15 min    
15 - 16 min    
16 - 17 min    
17 - 18 min    
18 - 19 min    
19 - 20 min    
20 - 21 min    
21 - 22 min    
22 - 23 min    
23 - 24 min    
24 - 25 min    
25 - 26 min    
26 - 27 min    
27 - 28 min    
28 - 29 min    
29 - 30 min    
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The treadmill grade/speed will be adjusted using the following protocol: 
 
1) If the heart rate is below the range of 70% to 75% of age-predicted maximal heart rate 
for two consecutive minutes increase the grade by 1.0%  
 
2) If the heart rate is above the range of 70% to 75% of age-predicted maximal heart rate 
for two consecutive minutes decrease the grade by 1%.   
 
3) If a grade of 0% elicits a heart rate above the range of 70% to 75% of age-predicted 
maximal heart rate for two consecutive minutes decrease the speed by 0.2 mph. 
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APPENDIX M 
MENU FOR BREAKFAST MEAL 
Breakfast Category Food Items* # of subjects 
Standard Breakfast (no 
food allergies/intolerances) 
 
• Plain bagel 
• Low fat milk (1% fat) 
• Margarine 
5 
Gluten and lactose free 
 
• Food for Life® gluten free brown rice 
bread 
• Peanut butter 
• Silk® original soymilk 
1 
Lactose free 
 
• Plain bagel 
• Lactaid® low fat milk (1% fat) 
• Margarine 
1 
Lactose free (subjects 
preferred no milk 
substitute) 
• Plain bagel 
• Nutz over Chocolate Luna Bar® 
• Margarine 
2 
 
* The caloric content of each meal was calculated to be 20% of each subject’s estimated energy 
requirement determined by the Mifflin-St. Jeor equation.  The amount of each food item was 
then adjusted so the macronutrient distribution was 55% carbohydrate, 30% fat and 15% protein 
for each subject.  Each subjectt received an identical meal at each experimental session. 
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APPENDIX N 
INDIVIDUAL CHANGES IN PLASMA INSULIN FOR EACH SUBJECT 
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REST: 
10-EX:  
30-EX: 
 
 
 
Individual changes in plasma insulin (μU/ml) for each subject 
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APPENDIX O  
INDIVIDUAL CHANGES IN PLASMA GLUCOSE FOR EACH SUBJECT 
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REST: 
10-EX:  
30-EX: 
 
 
 
 
Individual changes in plasma glucose (mg/dl) for each subject 
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APPENDIX P  
INSULIN AND GLUCOSE AUC FOR EACH INDIVIDUAL SUBJECT 
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